syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
BIRDSHOT CHORIORETINOPATHY	2.00826446	75.34235119040808
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	75.03230046744747
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
PITUITARY APOPLEXY	1.38049451	51.79083943399083
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.320621654	49.54464037337273
PERIPHERAL CONE DYSTROPHY	1.25	46.89518779215467
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1581403600000002	43.4489677374989
RETINITIS PIGMENTOSA 75; RP75	1.0666667	40.017228166510336
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.02930401	38.615523875334276
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.01243895	37.98281175067351
IDIOPATHIC INTRACRANIAL HYPERTENSION	1.00826446	37.82620095668434
MOWAT-WILSON SYNDROME; MOWS	1.000541419	37.53646219026713
TURCOT SYNDROME WITH POLYPOSIS	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
LEBER CONGENITAL AMAUROSIS 17	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.94270522	35.36667065963559
CRANIOPHARYNGIOMA	0.798843373	29.969527994682604
LAFORA DISEASE	0.78194566	29.33559085516826
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.08380087522927
MENINGIOMA	0.735725	27.601569630706397
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	26.9795748947475
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7046070139999999	26.434142592959482
ROLANDIC EPILEPSY	0.6114546000000001	22.939422634701458
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.61096717	22.921136137593027
TSH-SECRETING PITUITARY ADENOMA	0.595264119	22.332018117149204
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.5893574	22.110420759756817
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5885869730000001	22.081517304680702
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.5638200600000001	21.15235807574713
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.008600952602585
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
INHALATIONAL ANTHRAX	0.5172414	19.40490606950159
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5171773	19.402501284271608
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.390112100883027
PERSISTENT PLACOID MACULOPATHY	0.5133333	19.258289202773177
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5129803690000001	19.245048590355044
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.506359504	18.996659224337833
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.501086973	18.798854159229872
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	18.758075116861868
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
CREST SYNDROME	0.5	18.758075116861868
PAROXYSMAL HEMICRANIA	0.5	18.758075116861868
PINEOCYTOMA	0.5	18.758075116861868
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	18.758075116861868
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.479112819	17.97446849650689
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	16.954414913690158
NELSON SYNDROME	0.4519231	16.954414913690158
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44515220999999994	16.700397187234138
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43686985	16.38967492518435
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.434469819	16.299635001622757
CONGENITAL MYASTHENIC SYNDROME	0.434469819	16.299635001622757
JUVENILE GLAUCOMA	0.43124969999999996	16.17882853344829
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.424565264	15.928054228244578
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062604
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.363071274	13.621036460933475
LEBER HEREDITARY OPTIC NEUROPATHY	0.3581731	13.437275829278555
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
CENTRALOPATHIC EPILEPSY	0.3547009	13.30701225243702
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.354680204	13.306235818191784
NON-FUNCTIONING PITUITARY ADENOMA	0.34526411900000004	12.952980558718272
PROLACTINOMA	0.34526411900000004	12.952980558718272
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.34285699999999997	12.862674720683817
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.34285699999999997	12.862674720683817
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070942
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.33843316999999995	12.696709649795363
COG4-CDG	0.333878554	12.525837991682442
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	12.505370905857834
XQ21 MICRODELETION SYNDROME	0.31775367299999996	11.920894533585525
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.30170260000000004	11.31872006750506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252717
OPTIC ATROPHY 1; OPA1	0.28674451	10.7575501158555
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28674451	10.7575501158555
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.2849752	10.691172416085468
RETINAL CAPILLARY MALFORMATION	0.283056	10.619171420556906
NARP SYNDROME	0.27838767299999995	10.444033763484756
WILLIAMS-BEUREN SYNDROME; WBS	0.26522724	9.9503049819159
RETINOSCHISIS OF FOVEA	0.2652089	9.949616935720616
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.726409347644042
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.25865907	9.703892529435263
NEOVASCULAR GLAUCOMA	0.25826446	9.689088281391534
UVEAL MELANOMA	0.25826446	9.689088281391534
CATARACT 7; CTRCT7	0.25826446	9.689088281391534
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.256035929	9.605482377595024
ALLAN-HERNDON-DUDLEY SYNDROME	0.25581395	9.597154580082293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.59025175850389
OPTIC ATROPHY 9; OPA9	0.25549451	9.585170421051632
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	9.585170421051632
PALLISTER-HALL SYNDROME	0.252439494	9.470557981829202
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	9.399504644255543
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.250541419	9.399349514974325
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.250541419	9.399349514974325
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.250541419	9.399349514974325
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	9.379037558430934
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	9.379037558430934
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244048764	9.155770094578589
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951174
RETINITIS PUNCTATA ALBESCENS	0.2366153	8.876895142397611
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013935
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.229712554	8.617930686436377
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.135267030765906
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21647621	8.12135401638713
PITUITARY CARCINOMA	0.21382781	8.021996244108134
USHER SYNDROME TYPE 3	0.21096707000000003	7.914672292488513
RETINITIS PIGMENTOSA 18	0.2083333	7.8158633814874365
CRI-DU-CHAT SYNDROME	0.20581395000000002	7.721347068396106
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002376
USHER SYNDROME TYPE 1	0.20250361400000003	7.597156005696003
PREECLAMPSIA/ECLAMPSIA 1	0.202435359	7.594595340861798
PLACENTAL INSUFFICIENCY	0.20189394000000002	7.574283384318408
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.201086973	7.544009089112749
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.523697132569357
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.200541419	7.52354200328814
LINEAR VERRUCOUS NEVUS SYNDROME	0.200541419	7.52354200328814
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.503230046744748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.503230046744748
CARPENTER SYNDROME	0.2	7.503230046744748
HELLP SYNDROME	0.2	7.503230046744748
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.2	7.503230046744748
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.199003973	7.465862948175903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.19676231	7.381764382294523
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.105249346027848
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.18935242	7.103773835839156
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.86452884386067
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266897
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266897
UNILATERAL POLYMICROGYRIA	0.18042552	6.768870914317728
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.17785471399999997	6.672424170199967
RIFT VALLEY FEVER	0.17547247900000001	6.583051884047935
USHER SYNDROME TYPE 2	0.17493106000000003	6.562739927504542
MACULAR CORNEAL DYSTROPHY	0.173611	6.5132163582270115
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.17144216	6.4318498309541035
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130531
SLC39A8-CDG	0.16976856899999998	6.369063139568294
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496000000002	6.331411593548378
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496000000002	6.331411593548378
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.167753973	6.2934832533720355
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	6.252704211004034
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.16333045000000002	6.127529699941704
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.161921074	6.074655338189898
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.156639614	5.876515291376496
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.81113364539517
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.727283548976788
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14867095	5.57756169559043
JOUBERT SYNDROME 5	0.1464647	5.494791689137277
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14394397299999998	5.400223716307073
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.14394397299999998	5.400223716307073
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.37991175976368
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.135149674	5.070295473822787
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.13277126	4.981066536880795
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.927090325796625
PINEOBLASTOMA	0.131035929	4.915963598379556
CONE-ROD DYSTROPHY 2	0.13071191000000001	4.903807652896976
RETINITIS PIGMENTOSA 58	0.1291667	4.845837322394324
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.12847589399999998	4.819920940715965
PANHYPOPHYSITIS	0.125	4.689518779215467
ADENOHYPOPHYSITIS	0.125	4.689518779215467
SHEEHAN SYNDROME	0.125	4.689518779215467
XP21 MICRODELETION SYNDROME	0.12495636299999999	4.687881686967717
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.122614673	4.600030493126909
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.11977006999999998	4.493311939623608
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427327
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.425523257443287
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.117676519	4.414769965785646
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.11660550999999998	4.374589831239975
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.11219797299999999	4.209236010987279
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.11219797299999999	4.209236010987279
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.11165665400000002	4.188927806058911
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	4.188924054443887
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.11165241899999999	4.1887689251626705
GANGLIOCYTOMA	0.11111110000000002	4.168460720234302
SUDDEN INFANT DEATH SYNDROME	0.11111099999999999	4.168456968619277
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11111099999999999	4.168456968619277
MYOTONIA, POTASSIUM-AGGRAVATED	0.11111099999999999	4.168456968619277
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11111099999999999	4.168456968619277
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.11111099999999999	4.168456968619277
MUCOLIPIDOSIS III ALPHA/BETA	0.11111099999999999	4.168456968619277
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10869115400000001	4.077673662540803
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.10840760399999999	4.0670359581420295
OPTIC ATROPHY 5; OPA5	0.10817310000000001	4.058238270847622
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10768421900000001	4.0398973378052085
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.1074498	4.031102839383569
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	4.00518158060568
SALT-AND-PEPPER SYNDROME	0.10543916400000002	3.9556715171422363
BILATERAL POLYMICROGYRIA	0.10466076399999999	3.9264689458003046
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.10397634	3.900791992192739
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390427
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.10139849000000001	3.804080984312734
NOCARDIOSIS	0.10111611900000002	3.7934875114550874
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09980951000000002	3.7444685719143522
MELAS	0.09963481000000002	3.737914500468521
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	3.7206101761732153
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572894
SARCOSINEMIA	0.09849690400000001	3.6952246480206647
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.6913586087390793
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6913586087390793
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810906
SLC35A2-CDG	0.098026554	3.677578926758233
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	3.662396365855547
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.09517155	3.5704701677763504
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955697
RETINAL CONE DYSTROPHY 3B	0.09234231000000001	3.46432797488909
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.4613113012487964
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.09182010399999999	3.444736816140137
PRADER-WILLI SYNDROME	0.091612819	3.43696028093894
AICA-RIBOSIDURIA	0.09145051900000001	3.4308714097560076
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.09145051900000001	3.4308714097560076
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.09127926	3.4244464313831298
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	3.4105594532126147
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.0909091	3.4105594532126147
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	3.4105594532126147
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	3.4105594532126147
STURGE-WEBER SYNDROME	0.08989881900000002	3.3726575994383383
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.08882781000000001	3.332477464892668
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08825100000000001	3.310837774276354
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.08740997	3.279285566445285
NEUROTROPHIC KERATOPATHY	0.08593211	3.2238419486608745
SCHINZEL-GIEDION SYNDROME	0.08500986	3.1892426791078226
CITRULLINEMIA TYPE I	0.08387471900000001	3.146656558815363
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.08333334	3.1263461029179798
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	3.091991438664452
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	3.090987656548799
WHITE-SUTTON SYNDROME; WHSUS	0.081488564	3.0571372093544116
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.080910854	3.0354637542028873
GAUCHER DISEASE TYPE 2	0.08068786000000001	3.0270978777976687
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08063321400000001	3.0250477702519962
CONE-ROD DYSTROPHY 10	0.0803653	3.0149966683782785
USHER SYNDROME	0.07956821	2.9850929201884795
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904280999999999	2.9653819348556807
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.07883488300000001	2.957581314286034
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.07747587300000001	2.906596490956901
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868364
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	2.8858585760437547
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0761986	2.8586781251994218
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	2.844973475519042
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07550507999999999	2.832659924689329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.074003673	2.776332914115365
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.073777854	2.767861054585736
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07332254	2.750779426158218
CONE-ROD DYSTROPHY 8; CORD8	0.0726908	2.727078973409565
LEIGH SYNDROME; LS	0.07251557300000001	2.720505130952561
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	2.7072107954072875
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.700038045127952
SPONTANEOUS PERIODIC HYPOTHERMIA	0.07197001900000001	2.700038045127952
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.07197001900000001	2.700038045127952
TAKAYASU ARTERITIS	0.07197001900000001	2.700038045127952
SCLERODERMA	0.07197001900000001	2.700038045127952
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483056
ALAND ISLAND EYE DISEASE	0.07150901	2.6827427622248528
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.07143619	2.680010836164833
CLEFT LIP AND ALVEOLUS	0.07142860000000001	2.6797260885845593
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.6797260885845593
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.6797260885845593
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.6797260885845593
PYCNODYSOSTOSIS	0.07142860000000001	2.6797260885845593
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.6797260885845593
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6553706038528255
DISTAL MONOSOMY 12Q	0.069239254	2.597590255134957
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.069065519	2.5910723867741012
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06856063999999999	2.572131270360249
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	2.5707604302307088
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.06810997	2.555223866934417
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.067595454	2.5359212073807624
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.067212254	2.521545018611199
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
RETINITIS PIGMENTOSA 41	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.472380816536759
RETINITIS PIGMENTOSA 20	0.06566456	2.463481497991366
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.412723647371147
DIETHYLSTILBESTROL SYNDROME	0.06395896000000001	2.3994939521527274
BRONCHOPULMONARY DYSPLASIA	0.06395896000000001	2.3994939521527274
CHROMOSOME 16P13.2 DELETION SYNDROME	0.063586973	2.385538431975735
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.063586973	2.385538431975735
LEBER CONGENITAL AMAUROSIS	0.063586973	2.385538431975735
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06326349	2.3734025951496793
HADDAD SYNDROME	0.063041419	2.365071346151126
MULTIPLE SYSTEM ATROPHY	0.0625	2.3447593896077334
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.0625	2.3447593896077334
ARNOLD-CHIARI MALFORMATION TYPE I	0.0625	2.3447593896077334
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	2.3447593896077334
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	2.3447593896077334
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0625	2.3447593896077334
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0625	2.3447593896077334
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	2.3447593896077334
2Q24 MICRODELETION SYNDROME	0.061910969	2.322661214119413
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.06175601	2.3168477489953454
RHEUMATOID ARTHRITIS	0.0607197	2.2779693873466353
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.060640982999999996	2.275016228548687
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.059986744	2.2504716999359258
HYPOPLASMINOGENEMIA	0.0596073	2.236236421826641
JOUBERT SYNDROME 2	0.059265714	2.223421430132904
JOUBERT SYNDROME 3; JBTS3	0.05872016	2.2029543443082953
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.176728679487411
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.05802111	2.176728679487411
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.057818869999999994	2.1691414132641422
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.056642573	2.125011278292664
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.056642573	2.125011278292664
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0563492	2.1140050527501457
JOUBERT SYNDROME 7	0.056101154	2.1046993217492713
JOUBERT SYNDROME 1	0.056101154	2.1046993217492713
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492713
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.056097019000000005	2.1045441924680555
ACUTE BILIRUBIN ENCEPHALOPATHY	0.056097019000000005	2.1045441924680555
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.056097019000000005	2.1045441924680555
WOLFRAM SYNDROME	0.056097019000000005	2.1045441924680555
APNEA, OBSTRUCTIVE SLEEP	0.0555984	2.0858379271546656
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0842322359246626
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246626
GITELMAN SYNDROME	0.055555600000000004	2.0842322359246626
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0842322359246626
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05465477399999999	2.0504367123742173
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.054608173	2.048688422257176
CHROMOSOME 1P36 DELETION SYNDROME	0.053870773	2.021024013074828
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.053637669	2.0122788483907463
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.052020019	1.9515908479651634
JUVENILE XANTHOGRANULOMA	0.051742760000000006	1.9411891576675115
PEHO SYNDROME	0.051484814	1.931512016779323
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9238737285917369
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.05044311	1.8924312930162521
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8411746276625256
MOHR-TRANEBJAERG SYNDROME	0.04894842	1.8363562784234078
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.048517149999999995	1.8201766883121095
TRICHOTHIODYSTROPHY	0.048485504	1.818989452221813
17P11.2 MICRODUPLICATION SYNDROME	0.04840585399999999	1.8160012908556968
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.047767849999999994	1.7920658369419802
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.04744189399999999	1.7798372226763965
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.04734844	1.7763311883724542
NEUROFIBROMATOSIS TYPE 1	0.047184279	1.770172499633936
MENTAL RETARDATION, X-LINKED 98; MRX98	0.047182632999999995	1.770110748050651
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046841813999999996	1.7573245312441435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.046541473	1.746056893166797
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.046541473	1.746056893166797
ADENYLOSUCCINASE DEFICIENCY	0.046541473	1.746056893166797
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.046000054	1.7257449366234043
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.046000054	1.7257449366234043
HEREDITARY METHEMOGLOBINEMIA	0.045995919	1.7255898073421883
CONE-ROD DYSTROPHY, X-LINKED, 3	0.04575352	1.7164959300416838
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0454545	1.7052778507987958
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0454545	1.7052778507987958
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04542484399999999	1.7041652718474638
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.045400460000000004	1.7032504780401654
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04537224	1.7021917722805695
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.04537224	1.7021917722805695
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.045114299999999996	1.6925148564892827
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.661888697310583
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.044048764	1.6525400478338417
HYDROXYKYNURENINURIA	0.044023854	1.6516055205315197
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503036
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.631138434706911
LICHTENSTEIN SYNDROME	0.043478300000000004	1.631138434706911
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.631138434706911
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.631138434706911
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	1.631138434706911
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	1.631138434706911
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.631138434706911
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.631138434706911
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.631138434706911
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.631138434706911
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.631138434706911
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.631138434706911
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6232024183510694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6225267524853604
CANAVAN DISEASE	0.043061100000000005	1.6154866968294015
BIOTINIDASE DEFICIENCY	0.042873574	1.608451443240672
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
ALG13-CDG	0.0426748	1.6009942079941135
WEST SYNDROME	0.0426748	1.6009942079941135
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0426748	1.6009942079941135
CHERUBISM	0.04227	1.5858076703795025
COG2-CDG	0.04221225399999999	1.5836412627681054
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04202195399999999	1.576501939378628
GYRATE ATROPHY OF CHOROID AND RETINA	0.041540719000000004	1.5584478548209022
ALPERS-HUTTENLOCHER SYNDROME	0.041389704	1.5527823533933562
MENTAL RETARDATION, X-LINKED 106; MRX106	0.040905854	1.534630164102769
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.040901719	1.5344750348215526
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04084415000000001	1.5323152675687477
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04020156	1.5082077645900587
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.040015769	1.501237601521985
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.039661714	1.4879548209509839
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.039661714	1.4879548209509839
OPTIC ATROPHY 8	0.03951446	1.4824304177644674
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.039283524	1.473766588094092
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
ADNP SYNDROME	0.039262129	1.4729639300598416
OCULOCUTANEOUS ALBINISM	0.03920057	1.4706544733676037
OPTIC PATHWAY GLIOMA	0.039185033	1.4700715849414225
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.039092333	1.4665938378147563
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039092333	1.4665938378147563
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.038585553999999994	1.4475814407154597
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
ACHROMATOPSIA	0.038194439999999996	1.432908349132947
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.428416165303961
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
MARSHALL-SMITH SYNDROME; MRSHSS	0.03783066	1.4192607240009232
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310347
16P13.11 MICRODELETION SYNDROME	0.037582554	1.4099527420310347
COSTELLO SYNDROME; CSTLO	0.037520314	1.407617736840488
13Q12.3 MICRODELETION SYNDROME	0.037409780000000004	1.4034709266905536
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.037366263	1.4018383363808324
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.037290064	1.398979643249173
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.037274100000000004	1.398380735426842
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.389485656206426
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
CHRISTIANSON SYNDROME	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
OSTEOPETROSIS AND RELATED DISORDERS	0.0369623	1.3866831997839668
MYHRE SYNDROME	0.036952353	1.386310026637592
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.036780523999999995	1.3798636640590813
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.3785125574245642
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.3785125574245642
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.3785125574245642
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.3785125574245642
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.3785125574245642
ACHROMATOPSIA 7; ACHM7	0.03674451	1.3785125574245642
STARGARDT DISEASE	0.03674451	1.3785125574245642
19P13.3 MICRODUPLICATION SYNDROME	0.036415833999999994	1.3661818992303445
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.3603301301168886
ALSTROM SYNDROME; ALMS	0.036110714	1.354734971471031
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.03568607	1.3388039633711817
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
JUVENILE ABSENCE EPILEPSY	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
HALLERMANN-STREIFF SYNDROME; HSS	0.03561365	1.3360870437712553
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.035520753999999995	1.3326019434791432
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.035146914	1.3185769058757681
DYSOSTEOSCLEROSIS	0.035136919	1.3182019319541822
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.03506331299999999	1.3154405182000781
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.034712153999999995	1.302266384400154
SAETHRE-CHOTZEN SYNDROME	0.034708019	1.3021112551189378
PRADER-WILLI SYNDROME; PWS	0.034678663	1.3010099310126766
DOORS SYNDROME	0.03461480399999999	1.298614187174901
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.2911018031874995
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034152039999999995	1.2812530634281423
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
CHROMOSOME 17Q12 DELETION SYNDROME	0.03397144	1.2744776466959318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790924
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978761
RETINITIS PIGMENTOSA 11	0.03279521	1.230350025306519
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.03271235399999999	1.2272415871627533
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.03252151	1.2200818549875487
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
AICARDI SYNDROME	0.0322581	1.2101997258544837
GIANT CELL ARTERITIS	0.03207396	1.2032915019504458
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.2032915019504458
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.032062943999999996	1.2028782240394709
TYSHCHENKO SYNDROME	0.031676154	1.1883673522905691
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.03152996	1.1828827162233002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03134496	1.1759422284300611
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03134496	1.1759422284300611
CRANIOSYNOSTOSIS 2	0.031295359	1.1740813898623184
1P36 DELETION SYNDROME	0.031278533	1.1734501431184854
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.1723796948038667
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.1723796948038667
CONE-ROD DYSTROPHY 18	0.03125	1.1723796948038667
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.17151344689497
TURNPENNY-FRY SYNDROME; TPFS	0.031010894	1.163409358186082
PITT-HOPKINS SYNDROME	0.030929283	1.1603476276493576
PRADER-WILLI-LIKE SYNDROME	0.030898783	1.159203385067229
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.03082266	1.1563475431629873
OCULODENTODIGITAL DYSPLASIA	0.030732979	1.1529830572938766
ACHONDROPLASIA	0.03046534	1.142942272361473
BARATELA-SCOTT SYNDROME	0.030387863999999997	1.1400356711059652
BAKER-GORDON SYNDROME; BAGOS	0.030357363999999998	1.1388914285238365
WILLIAMS SYNDROME	0.03019156	1.1326711007504842
CARTILAGE-HAIR HYPOPLASIA	0.03019156	1.1326711007504842
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.03019156	1.1326711007504842
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.030092559999999997	1.1289570018773456
1Q21.1 MICRODELETION SYNDROME	0.030007913	1.1257813723085117
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.029946643	1.1234827577836912
RETINAL CONE DYSTROPHY 4	0.02993567	1.1230710930671766
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.1192418196128204
VASCULAR EHLERS-DANLOS SYNDROME	0.029782213999999998	1.1173140147169103
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581094
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.029658373000000002	1.112667977155816
SCLEROSTEOSIS 1; SOST1	0.02954106	1.108266845023447
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.0993736416105429
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.0993736416105429
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.0993736416105429
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.0993736416105429
BECKWITH-WIEDEMANN SYNDROME	0.029236659999999998	1.0968469288923013
XIA-GIBBS SYNDROME	0.029116954	1.0923560206124232
AURICULOCONDYLAR SYNDROME	0.029116954	1.0923560206124232
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.029116954	1.0923560206124232
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	1.092200891331207
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.029112819	1.092200891331207
POTOCKI-LUPSKI SYNDROME	0.028864713	1.0828929093613187
RAHMAN SYNDROME	0.028701814	1.0767815660043951
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.0718889347878144
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.0718889347878144
HURLER-SCHEIE SYNDROME	0.0285714	1.0718889347878144
SCHEIE SYNDROME	0.0285714	1.0718889347878144
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.0718889347878144
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0285714	1.0718889347878144
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.028369173	1.0643021562744992
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0632588696526495
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0632588696526495
BETA-UREIDOPROPIONASE DEFICIENCY	0.028270504000000002	1.060600475247088
PEHO-LIKE SYNDROME; PEHOL	0.028270504	1.0606004752470877
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.02822104	1.0587447763919269
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.02822104	1.0587447763919269
KOOLEN-DE VRIES SYNDROME	0.028113973	1.0547280347348527
AMISH INFANTILE EPILEPSY SYNDROME	0.027970509999999997	1.049345855273872
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.027807464	1.0432289970428645
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623313
16P13.2 MICRODELETION SYNDROME	0.027734223	1.0404812766835962
SCHAAF-YANG SYNDROME; SHFYNG	0.027734223	1.0404812766835962
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.027621859999999998	1.0362658494948842
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.027572554	1.0344160781914604
DISTAL MONOSOMY 6P	0.027572554	1.0344160781914604
RENPENNING SYNDROME	0.027568419	1.034260948910244
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.034260948910244
EMANUEL SYNDROME	0.027337722999999998	1.0256061231159246
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	1.0242171626858216
STÃœVE-WIEDEMANN SYNDROME	0.0272822	1.0235231139064978
CRANIOECTODERMAL DYSPLASIA	0.027027	1.0139489923668514
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.027027	1.0139489923668514
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
ACRAL PEELING SKIN SYNDROME	0.027027	1.0139489923668514
MICROPHTHALMIA, ISOLATED 1	0.027027	1.0139489923668514
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.027027	1.0139489923668514
HYPEROPIA, HIGH	0.027027	1.0139489923668514
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668514
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.027027	1.0139489923668514
NANOPHTHALMOS	0.027027	1.0139489923668514
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.027027	1.0139489923668514
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.027027	1.0139489923668514
RETINITIS PIGMENTOSA 83; RP83	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 79	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 19	0.02677111	1.004348984683544
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 14	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 72; RP72	0.02677111	1.004348984683544
RETINITIS PIGMENTOSA 10; RP10	0.02677111	1.004348984683544
CHERUBISM	0.02677111	1.004348984683544
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9942027418528334
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.026474383	0.9932169299731418
MICROSPORIDIOSIS	0.026047279	0.9771936321437174
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.026035464	0.976750378828706
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.025932964	0.9729049734297492
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.025932964	0.9729049734297492
1P21.3 MICRODELETION SYNDROME	0.025683563999999996	0.9635484455614584
CONGENITAL ENTEROVIRUS INFECTION	0.025644760000000003	0.9620926688677892
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.025644760000000003	0.9620926688677892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025621114	0.9612055619793626
TOXIC EPIDERMAL NECROLYSIS	0.025505859999999998	0.9568816756003249
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025147104	0.943422531607075
GORLIN-CHAUDHRY-MOSS SYNDROME	0.025138009999999995	0.9430813597368495
CARDIOFACIOCUTANEOUS SYNDROME	0.025077913999999996	0.9408267891724036
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02507556	0.9407384761547536
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.02461252	0.9233669979505301
CROUZON SYNDROME	0.024539279	0.920619277591262
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.024539279	0.920619277591262
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.024355054	0.9137078648144543
ISOLATED PLAGIOCEPHALY	0.024355054	0.9137078648144543
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.024350919000000002	0.9135527355332379
SNEDDON SYNDROME	0.024350919000000002	0.9135527355332379
LYNCH SYNDROME	0.024350919000000002	0.9135527355332379
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.024350919000000002	0.9135527355332379
FAMILIAL COLORECTAL CANCER TYPE X	0.024350919000000002	0.9135527355332379
FAMILIAL THROMBOCYTOSIS	0.024350919000000002	0.9135527355332379
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02418584	0.9073596069688048
AGEL AMYLOIDOSIS	0.02399786	0.9003073210478696
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023814213	0.8934175926058968
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.8932407789898453
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.8932407789898453
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	0.8932407789898453
PITUICYTOMA	0.0238095	0.8932407789898453
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0238095	0.8932407789898453
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.0238095	0.8932407789898453
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.8932407789898453
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.0238095	0.8932407789898453
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.8932407789898453
CRYPTOCOCCOSIS	0.023806919000000003	0.8931439498060921
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.023678113999999997	0.8883116820752373
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.023429283	0.8789765008964296
16P11.2P12.2 MICRODELETION SYNDROME	0.023272794	0.8731056360625042
6Q25 MICRODELETION SYNDROME	0.023029922999999997	0.8639940511390896
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02272724	0.8526385502378954
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.022643378999999998	0.8494924083631452
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064701
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064701
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064701
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064701
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.8424834535957296
INFANTILE REFSUM DISEASE	0.022363573	0.838995164430848
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.022342309999999997	0.8381974585284282
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.022342309999999997	0.8381974585284282
HERMANSKY-PUDLAK SYNDROME	0.022342309999999997	0.8381974585284282
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.022342309999999997	0.8381974585284282
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.022342309999999997	0.8381974585284282
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.022015233	0.8259267886584324
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.021993514000000002	0.8251119753915064
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02196306	0.8239694585522884
SIALURIA	0.021920273	0.8223642550322381
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.021920273	0.8223642550322381
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.8223642550322381
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021920273	0.8223642550322381
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.021911	0.8220163677711207
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02170111	0.8141421029985645
GALACTOSEMIA	0.021492933000000002	0.8063321033913587
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.021423883	0.80374161321772
OROFACIODIGITAL SYNDROME TYPE 14	0.021378854	0.8020522984888456
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.021378854	0.8020522984888456
ALEXANDER DISEASE	0.021374719	0.8018971692076292
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076292
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076292
COFFIN-LOWRY SYNDROME	0.021374719	0.8018971692076292
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.021374719	0.8018971692076292
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7990607606692084
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997377
RETINITIS PIGMENTOSA	0.0212766	0.7982161220628465
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.7982161220628465
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 6	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 69	0.0212766	0.7982161220628465
RETINITIS PIGMENTOSA 1	0.0212766	0.7982161220628465
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.020937633	0.7854993851665718
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.020937633	0.7854993851665718
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.020928259999999997	0.7851477462904309
CRANDALL SYNDROME	0.0208333	0.7815852126642366
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.7815852126642366
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.7815852126642366
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642366
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.7815852126642366
POLYARTERITIS NODOSA	0.0208333	0.7815852126642366
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642366
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642366
DERMOIDS OF CORNEA	0.0208333	0.7815852126642366
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.7815852126642366
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7815852126642366
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642366
INFANTILE MYOFIBROMATOSIS	0.0208333	0.7815852126642366
ACROMEGALY	0.0208333	0.7815852126642366
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642366
IMINOGLYCINURIA	0.0208333	0.7815852126642366
SOMATOMAMMOTROPINOMA	0.0208333	0.7815852126642366
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642366
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642366
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.7815852126642366
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642366
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642366
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642366
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.7815852126642366
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642366
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642366
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642366
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642366
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642366
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.7815852126642366
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7815852126642366
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642366
GLAUCOMA - SLEEP APNEA	0.0208333	0.7815852126642366
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642366
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642366
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642366
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642366
HYPOCHONDROPLASIA	0.0208333	0.7815852126642366
611426 TENTED EYEBROWS	0.0208333	0.7815852126642366
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642366
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0208333	0.7815852126642366
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642366
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642366
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642366
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.7815852126642366
APNEA, CENTRAL SLEEP	0.0208333	0.7815852126642366
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642366
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.020823294	0.7812098260649981
OPTIC ATROPHY 11; OPA11	0.020823294	0.7812098260649981
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.020823294	0.7812098260649981
ALSTRÃ–M SYNDROME	0.020809673	0.7806988185826645
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.020809673	0.7806988185826645
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.020762933	0.7789453137207404
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
SPINOCEREBELLAR ATAXIA TYPE 7	0.020648064	0.7746358710595427
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.020643039999999998	0.7744473899207684
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443213999999998	0.7669506876841643
STEVENS-JOHNSON SYNDROME	0.02040596	0.7655530610233573
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.020392079	0.7650322993419629
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.020392079	0.7650322993419629
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020304313999999997	0.7617396944167
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02027774	0.7607427402403891
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02027774	0.7607427402403891
RETINITIS PIGMENTOSA 80; RP80	0.020268254	0.7603868620392721
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.020264119	0.7602317327580557
MIRAGE SYNDROME; MIRAGE	0.020222313000000002	0.7586633325813846
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.020217379	0.7584782278961314
GAUCHER DISEASE, PERINATAL LETHAL	0.020097979000000002	0.7539987995582248
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.020053968999999998	0.7523477137864385
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0197227	0.7399197762146631
OCULOCEREBRORENAL SYNDROME OF LOWE	0.019688669	0.7386430641060593
MENKES DISEASE	0.019676759000000002	0.7381962467567756
LEUKOCYTE ADHESION DEFICIENCY	0.019676759000000002	0.7381962467567756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.7381662713527389
XQ12-Q13.3 DUPLICATION SYNDROME	0.01967596	0.7381662713527389
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.019234639	0.7216096064154418
CONE DYSTROPHY 3	0.01919311	0.7200515982123854
CONE-ROD DYSTROPHY 16	0.01919311	0.7200515982123854
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395406
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.018988524	0.7123763191006688
PERMANENT NEONATAL DIABETES MELLITUS	0.018741004	0.7030903215948174
TRANSIENT NEONATAL DIABETES MELLITUS	0.018741004	0.7030903215948174
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.018610693	0.6982015545417107
JOUBERT SYNDROME WITH OCULAR DEFECT	0.018610693	0.6982015545417107
CHARGE SYNDROME	0.018568493999999998	0.6966184105179977
TRISOMY 13	0.018564359	0.6964632812367813
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
DISTAL MONOSOMY 10Q	0.018499343	0.6940241312131856
6Q TERMINAL DELETION SYNDROME	0.018448113000000002	0.692102178836712
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.018448113000000002	0.692102178836712
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018392943999999998	0.6900324503444675
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.018358309	0.6887330784811226
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.018329943	0.6876688953635929
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.018069274	0.6778895979983183
PREECLAMPSIA	0.018022939999999998	0.6761513246933888
FETAL PARVOVIRUS SYNDROME	0.018022939999999998	0.6761513246933888
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017853803999999997	0.6698059931074577
GABRIELE-DE VRIES SYNDROME	0.017847389999999998	0.6695653645198586
CURRARINO SYNDROME	0.017786954	0.6672980384643334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.017786954	0.6672980384643334
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.017786954	0.6672980384643334
WHIM SYNDROME	0.017782819000000002	0.667142909183117
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.017782819000000002	0.667142909183117
PGM3-CDG	0.017782819000000002	0.667142909183117
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01752372	0.6574225121737093
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01752372	0.6574225121737093
ZTTK SYNDROME; ZTTKS	0.017465373000000003	0.6552335573560223
AYMÃ‰-GRIPP SYNDROME	0.017408714	0.6531079297999297
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.017404579	0.6529528005187133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.017317623000000004	0.6496905461589897
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
CALCIPHYLAXIS	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
RETICULAR DYSGENESIA	0.0172414	0.6468309526397245
DESMOID TUMOR	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397245
CYCLIC NEUTROPENIA	0.0172414	0.6468309526397245
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
WISKOTT-ALDRICH SYNDROME	0.0172414	0.6468309526397245
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
OMENN SYNDROME	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397245
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
BULLOUS IMPETIGO	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0172414	0.6468309526397245
MELIOIDOSIS	0.0172414	0.6468309526397245
RAT-BITE FEVER	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
LAMELLAR ICHTHYOSIS	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
LEGIONELLOSIS	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
RADIATION PROCTITIS	0.0172414	0.6468309526397245
HIRSCHSPRUNG DISEASE	0.0172414	0.6468309526397245
NEUROLEPTIC MALIGNANT SYNDROME	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
IMMUNODEFICIENCY 46; IMD46	0.0172414	0.6468309526397245
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397245
PLAGUE	0.0172414	0.6468309526397245
RETICULAR DYSGENESIS	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0172414	0.6468309526397245
PYOMYOSITIS	0.0172414	0.6468309526397245
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
CLASSIC GALACTOSEMIA	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
ACQUIRED PURPURA FULMINANS	0.0172414	0.6468309526397245
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0172414	0.6468309526397245
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
X-LINKED AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397245
SEVERE COMBINED IMMUNODEFICIENCY	0.0172414	0.6468309526397245
FELTY SYNDROME	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
CHRONIC GRANULOMATOUS DISEASE	0.0172414	0.6468309526397245
SECONDARY SHORT BOWEL SYNDROME	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
ISOLATED AGAMMAGLOBULINEMIA	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
CONGENITAL DISORDER OF GLYCOSYLATION	0.017215973	0.6458770294877315
MULTIPLE CARBOXYLASE DEFICIENCY	0.017215973	0.6458770294877315
CEDNIK SYNDROME	0.017215973	0.6458770294877315
ALG11-CDG	0.017215973	0.6458770294877315
RECOMBINANT 8 SYNDROME	0.017215973	0.6458770294877315
ALG3-CDG	0.017215973	0.6458770294877315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.017098354	0.6414644174133912
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.017040423000000002	0.6392910693142014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.017040423000000002	0.6392910693142014
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017040423000000002	0.6392910693142014
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.017021763999999998	0.6385910554669902
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.017021763999999998	0.6385910554669902
XYLOSIDASE DEFICIENCY	0.016982219000000003	0.6371074793059978
OROFACIODIGITAL SYNDROME TYPE 2	0.016847064	0.6320369840211587
GERODERMA OSTEODYSPLASTICA	0.016674553999999998	0.625565072944339
FARBER DISEASE	0.016674553999999998	0.625565072944339
CONGENITAL HYPOTHYROIDISM	0.016674553999999998	0.625565072944339
INSULINOMA	0.016670419	0.6254099436631226
LINEAR NEVUS SEBACEUS SYNDROME	0.016670419	0.6254099436631226
DYSEQUILIBRIUM SYNDROME	0.016670419	0.6254099436631226
DPM1-CDG	0.016670419	0.6254099436631226
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016670419	0.6254099436631226
CHOREOACANTHOCYTOSIS	0.016670419	0.6254099436631226
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016670419	0.6254099436631226
CEREBROTENDINOUS XANTHOMATOSIS	0.016670419	0.6254099436631226
MPDU1-CDG	0.016670419	0.6254099436631226
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016670419	0.6254099436631226
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.016670419	0.6254099436631226
BENIGN FAMILIAL INFANTILE EPILEPSY	0.016670419	0.6254099436631226
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.016499004	0.6189791127708089
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.01649786	0.6189361942949415
NON-DISTAL MONOSOMY 20Q	0.016494869000000002	0.6188239834895924
TRISOMY 8P	0.016494869000000002	0.6188239834895924
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.016370333	0.6141518722040854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.016334883	0.6128219246782999
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.016334883	0.6128219246782999
PHELAN-MCDERMID SYNDROME	0.016334883	0.6128219246782999
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.016334883	0.6128219246782999
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.016334883	0.6128219246782999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.016334883	0.6128219246782999
TETRASOMY 9P	0.016314213	0.612046465852969
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.016314213	0.612046465852969
GAUCHER DISEASE	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.016133959	0.6052840297087392
WAARDENBURG SYNDROME	0.016128999999999998	0.6050979871197301
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.6050979871197301
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.6050979871197301
ALKAPTONURIA	0.016128999999999998	0.6050979871197301
STERNAL CLEFT	0.016128999999999998	0.6050979871197301
X-LINKED RETINOSCHISIS	0.016128999999999998	0.6050979871197301
NARCOLEPSY TYPE 1	0.016128999999999998	0.6050979871197301
SILENT SINUS SYNDROME	0.016128999999999998	0.6050979871197301
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.6050979871197301
EEM SYNDROME	0.016128999999999998	0.6050979871197301
AMYLOIDOSIS	0.016128999999999998	0.6050979871197301
CENTRAL NEUROCYTOMA	0.016128999999999998	0.6050979871197301
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.6050979871197301
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.6050979871197301
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.6050979871197301
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.6050979871197301
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.6050979871197301
WAARDENBURG SYNDROME TYPE 1	0.016128999999999998	0.6050979871197301
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.6050979871197301
DIPROSOPUS	0.016128999999999998	0.6050979871197301
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.6050979871197301
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.6050979871197301
ARACHNOIDITIS	0.016128999999999998	0.6050979871197301
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.6050979871197301
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.6050979871197301
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.6050979871197301
ACRORENAL SYNDROME	0.016128999999999998	0.6050979871197301
SOTOS SYNDROME 2	0.01595345	0.5985120269462
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.01595345	0.5985120269462
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015909933	0.596879436636479
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01588063	0.5957801008861802
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015852263999999998	0.5947159177686503
JOUBERT SYNDROME 30; JBTS30	0.015840743	0.5942836942018077
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01579181	0.5924479164224209
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015592539999999998	0.5849720731653466
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5804106345230291
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230291
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230291
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5804106345230291
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5804106345230291
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01522724	0.5712674234849674
JACOBSEN SYNDROME	0.01522724	0.5712674234849674
FUMARASE DEFICIENCY; FMRD	0.015204414	0.5704110798397324
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5704110798397324
COFFIN-SIRIS SYNDROME 1; CSS1	0.015154483	0.5685378609424123
NEMALINE MYOPATHY 2; NEM2	0.01507321	0.565488810864467
STICKLER SYNDROME	0.01503311	0.5639844132400946
LOWE OCULOCEREBRORENAL SYNDROME	0.015014439	0.5632839491990808
COHEN SYNDROME	0.015014439	0.5632839491990808
CINCA SYNDROME	0.014973014000000002	0.5617298426756488
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984202
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.014863313999999999	0.5576143209950093
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.014829979	0.5563637201269681
ADRENOLEUKODYSTROPHY	0.014829979	0.5563637201269681
DONNAI-BARROW SYNDROME	0.014785572999999998	0.5546977779596893
HSD10 DISEASE	0.014785572999999998	0.5546977779596893
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.014668233000000001	0.5502956328912643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.014668233000000001	0.5502956328912643
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5499439940151235
FANCONI ANEMIA	0.014613064	0.54822590439902
CONGENITAL TOXOPLASMOSIS	0.014548833	0.5458162045533576
Ã…LAND ISLANDS EYE DISEASE	0.014503519999999999	0.5441162352378168
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.014503519999999999	0.5441162352378168
RETINAL DYSTROPHY AND OBESITY; RDOB	0.014503519999999999	0.5441162352378168
EDICT SYNDROME	0.014503519999999999	0.5441162352378168
MEGALOCORNEA	0.014503519999999999	0.5441162352378168
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.5412627568510399
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.014420272999999999	0.54099312827931
DUANE RETRACTION SYNDROME	0.014420272999999999	0.54099312827931
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.014420272999999999	0.54099312827931
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.014420272999999999	0.54099312827931
DIGEORGE SYNDROME; DGS	0.014420272999999999	0.54099312827931
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.014420272999999999	0.54099312827931
CHÃ‰DIAK-HIGASHI SYNDROME	0.014420272999999999	0.54099312827931
MUENKE SYNDROME	0.014420272999999999	0.54099312827931
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014420272999999999	0.54099312827931
PHACE SYNDROME	0.014420272999999999	0.54099312827931
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.01428856	0.5360517635835756
SENIOR-LOKEN SYNDROME	0.014244153999999998	0.5343858214162969
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5343858214162969
MEDULLOBLASTOMA	0.014244153999999998	0.5343858214162969
JOUBERT SYNDROME 35; JBTS35	0.014244153999999998	0.5343858214162969
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014244153999999998	0.5343858214162969
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.014244153999999998	0.5343858214162969
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5343858214162969
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5343858214162969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5343858214162969
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5343858214162969
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.014244153999999998	0.5343858214162969
NEURAMINIDASE DEFICIENCY	0.014240018999999998	0.5342306921350803
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.014240018999999998	0.5342306921350803
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.014240018999999998	0.5342306921350803
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.014240018999999998	0.5342306921350803
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.014240018999999998	0.5342306921350803
KNOBLOCH SYNDROME	0.014240018999999998	0.5342306921350803
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.014240018999999998	0.5342306921350803
SIALIDOSIS TYPE 1	0.014240018999999998	0.5342306921350803
BRITTLE CORNEA SYNDROME	0.01407841	0.5281677446119586
WRINKLY SKIN SYNDROME	0.013933794	0.5227423090297584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013933794	0.5227423090297584
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013878854	0.5206811717359175
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.013878854	0.5206811717359175
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.013874718999999999	0.5205260424547011
PFEIFFER SYNDROME TYPE 3	0.013874718999999999	0.5205260424547011
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.013874718999999999	0.5205260424547011
CLASSIC HOMOCYSTINURIA	0.013874718999999999	0.5205260424547011
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.013874718999999999	0.5205260424547011
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.013845363	0.51942471834844
MONOSOMY 22Q13.3	0.013845363	0.51942471834844
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.5139187355916879
ANIRIDIA 3	0.013698599999999998	0.5139187355916879
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916879
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.5139187355916879
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
KID SYNDROME	0.013698599999999998	0.5139187355916879
REFSUM DISEASE	0.013698599999999998	0.5139187355916879
CHOROIDEREMIA	0.013698599999999998	0.5139187355916879
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916879
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5139187355916879
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.5139187355916879
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.5139187355916879
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.013698599999999998	0.5139187355916879
BASAL LAMINAR DRUSEN	0.013698599999999998	0.5139187355916879
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.5139187355916879
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.5139187355916879
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.5139187355916879
BEHR SYNDROME	0.013698599999999998	0.5139187355916879
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.5139187355916879
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.5139187355916879
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.013698599999999998	0.5139187355916879
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013510793	0.506872939964743
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.013510793	0.506872939964743
RENPENNING SYNDROME 1; RENS1	0.013509959	0.5068416514954481
X SMALL RINGS	0.013401754	0.502782216459408
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.013397613000000001	0.5026268620812903
DESMOSTEROLOSIS	0.01338824	0.5022752232051495
ISOLATED ECTOPIA LENTIS	0.0133333	0.5002140859113087
CROUZON DISEASE	0.0133333	0.5002140859113087
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.0133333	0.5002140859113087
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.5002140859113087
MORNING GLORY DISC ANOMALY	0.0133333	0.5002140859113087
BENCZE SYNDROME	0.0133333	0.5002140859113087
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0133333	0.5002140859113087
SPONDYLOOCULAR SYNDROME; SOS	0.0133333	0.5002140859113087
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.0133333	0.5002140859113087
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.0133333	0.5002140859113087
CATARACT 17, MULTIPLE TYPES	0.0133333	0.5002140859113087
MARSHALL SYNDROME	0.0133333	0.5002140859113087
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0133333	0.5002140859113087
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.5002140859113087
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.5002140859113087
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.013303944	0.4991127618050475
KRABBE DISEASE	0.012969373999999999	0.48656098342135057
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.012965239	0.48640585414013415
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012856194000000001	0.4823149055378977
EPIDERMAL NEVUS SYNDROME	0.012719124	0.47717256682536124
2Q23.1 MICRODUPLICATION SYNDROME	0.012719124	0.47717256682536124
16Q24.3 MICRODELETION SYNDROME	0.012714989	0.4770174375441447
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.012654893	0.4747628669796989
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994921
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.012515992999999998	0.4695518737122346
MICROPHTHALMIA, ISOLATED 5	0.01243895	0.4666615169497779
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01243895	0.4666615169497779
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01242382	0.46609389759674164
SCHWARTZ-JAMPEL SYNDROME	0.01242382	0.46609389759674164
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01242382	0.46609389759674164
MICRO SYNDROME	0.012414873	0.4657582406006005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012395432999999999	0.46502892664005685
TARP SYNDROME	0.012240173	0.45920416915476897
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01217357	0.4567054810007523
X-LINKED RECESSIVE OCULAR ALBINISM	0.01217357	0.4567054810007523
LOWRY-WOOD SYNDROME	0.01217357	0.4567054810007523
OCULAR ALBINISM	0.01217357	0.4567054810007523
PELIZAEUS-MERZBACHER DISEASE	0.012109339	0.45429578115508995
ZELLWEGER SYNDROME	0.012109339	0.45429578115508995
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.4516889714560996
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.4516889714560996
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4516889714560996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.4516889714560996
PERLMAN SYNDROME	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4516889714560996
RING CHROMOSOME 14 SYNDROME	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4516889714560996
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.4516889714560996
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.4516889714560996
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4516889714560996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.011959423	0.44867150997665106
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.011869319	0.44529115477599157
COG5-CDG	0.011869319	0.44529115477599157
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.011694619	0.43873708333016004
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.4321339032436726
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.4321339032436726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.4315735245076314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.4315735245076314
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.011503673	0.4315735245076314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.4315735245076314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011503673	0.4315735245076314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.4315735245076314
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.4315735245076314
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.4315735245076314
PEHO SYNDROME; PEHO	0.011503673	0.4315735245076314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.4315735245076314
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.011503673	0.4315735245076314
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.011503673	0.4315735245076314
HYPEREKPLEXIA 4; HKPX4	0.011503673	0.4315735245076314
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.4315735245076314
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.4315735245076314
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.011448504	0.42950379601538713
CORNELIA DE LANGE SYNDROME 1	0.011444369	0.4293486667341707
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.4287728313442332
JACOBSEN SYNDROME	0.011384273	0.4270940961697249
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011384273	0.4270940961697249
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011384273	0.4270940961697249
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011384273	0.4270940961697249
GALLOWAY-MOWAT SYNDROME	0.011384273	0.4270940961697249
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011384273	0.4270940961697249
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011195973	0.42002980508071464
HELSMOORTEL-VAN DER AA SYNDROME	0.011195973	0.42002980508071464
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011195973	0.42002980508071464
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0111532	0.4184251267867676
PRIMARY PULMONARY HYPOPLASIA	0.0111532	0.4184251267867676
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010962254000000001	0.411261567964239
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.010962254000000001	0.411261567964239
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.010958119	0.41110643868302255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.41110643868302255
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010958119	0.41110643868302255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.41110643868302255
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.41110643868302255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.41110643868302255
PITT-HOPKINS-LIKE SYNDROME	0.010958119	0.41110643868302255
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.41110643868302255
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.010958119	0.41110643868302255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.41110643868302255
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010958119	0.41110643868302255
DEND SYNDROME	0.010958119	0.41110643868302255
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.41110643868302255
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01090295	0.4090367101907782
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010842854	0.40678213962633236
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010842854	0.40678213962633236
PEDIATRIC-ONSET GRAVES DISEASE	0.010842854	0.40678213962633236
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.010842854	0.40678213962633236
ROIFMAN SYNDROME; RFMN	0.010842854	0.40678213962633236
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.010838719	0.40662701034511595
CORNELIA DE LANGE SYNDROME	0.010838719	0.40662701034511595
MICROFORM HOLOPROSENCEPHALY	0.010838719	0.40662701034511595
LOWRY-MACLEAN SYNDROME	0.010699819	0.4014160170776516
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.010520933	0.3947049030269417
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010520933	0.3947049030269417
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.010520933	0.3947049030269417
SCHINDLER DISEASE, TYPE I	0.010520933	0.3947049030269417
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010520933	0.3947049030269417
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010520933	0.3947049030269417
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010520933	0.3947049030269417
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010520933	0.3947049030269417
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010520933	0.3947049030269417
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010520933	0.3947049030269417
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010520933	0.3947049030269417
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010520933	0.3947049030269417
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.010520933	0.3947049030269417
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010520933	0.3947049030269417
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010520933	0.3947049030269417
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.010520933	0.3947049030269417
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.010520933	0.3947049030269417
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010520933	0.3947049030269417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.010520933	0.3947049030269417
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.010520933	0.3947049030269417
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010520933	0.3947049030269417
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.010520933	0.3947049030269417
GAUCHER DISEASE, TYPE II	0.010346233	0.38815083158111024
PROPIONIC ACIDEMIA	0.010346233	0.38815083158111024
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010346233	0.38815083158111024
GENITOPATELLAR SYNDROME	0.010346233	0.38815083158111024
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010346233	0.38815083158111024
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.010346233	0.38815083158111024
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.010346233	0.38815083158111024
JOUBERT SYNDROME WITH RENAL DEFECT	0.010346233	0.38815083158111024
OROFACIODIGITAL SYNDROME TYPE 6	0.010346233	0.38815083158111024
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010346233	0.38815083158111024
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.010346233	0.38815083158111024
JOUBERT SYNDROME	0.010346233	0.38815083158111024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.010346233	0.38815083158111024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.010346233	0.38815083158111024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010346233	0.38815083158111024
48,XXYY SYNDROME	0.010346233	0.38815083158111024
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.010346233	0.38815083158111024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.010346233	0.38815083158111024
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.010346233	0.38815083158111024
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.010346233	0.38815083158111024
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010346233	0.38815083158111024
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.010346233	0.38815083158111024
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.38815083158111024
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010346233	0.38815083158111024
WIEACKER-WOLFF SYNDROME	0.010346233	0.38815083158111024
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.010346233	0.38815083158111024
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0102973	0.3863150538017235
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0102973	0.3863150538017235
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0102973	0.3863150538017235
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0102973	0.3863150538017235
TEMPLE SYNDROME	0.0102973	0.3863150538017235
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0102973	0.3863150538017235
SILVER-RUSSELL SYNDROME	0.0102973	0.3863150538017235
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0102973	0.3863150538017235
VACTERL/VATER ASSOCIATION	0.0102973	0.3863150538017235
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.0102973	0.3863150538017235
DIAMOND-BLACKFAN ANEMIA 1	0.0102973	0.3863150538017235
YUNIS-VARON SYNDROME	0.0102973	0.3863150538017235
RESTRICTIVE DERMOPATHY, LETHAL	0.0102973	0.3863150538017235
PEMPHIGOID GESTATIONIS	0.0102973	0.3863150538017235
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010095983	0.37876241498512087
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.010095983	0.37876241498512087
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.010095983	0.37876241498512087
OCULOECTODERMAL SYNDROME; OES	0.010095983	0.37876241498512087
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.010095983	0.37876241498512087
DESANTO-SHINAWI SYNDROME	0.010095983	0.37876241498512087
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.010095983	0.37876241498512087
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.010065483	0.3776181724029923
MULTIPLE SULFATASE DEFICIENCY	0.010065483	0.3776181724029923
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010065483	0.3776181724029923
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.009979514	0.3743929464835493
YOU-HOOVER-FONG SYNDROME; YHFS	0.009979514	0.3743929464835493
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.009979514	0.3743929464835493
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009975379	0.37423781720233285
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.009975379	0.37423781720233285
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.009975379	0.37423781720233285
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009975379	0.37423781720233285
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009975379	0.37423781720233285
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.009975379	0.37423781720233285
WITTEVEEN-KOLK SYNDROME	0.009925353	0.3723610342707406
CHROMOSOME 1P35 DELETION SYNDROME	0.009925353	0.3723610342707406
KOOLEN-DE VRIES SYNDROME; KDVS	0.009925353	0.3723610342707406
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.3678388750377178
OROFACIODIGITAL SYNDROME XVI; OFD16	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377178
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377178
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3678388750377178
JOUBERT SYNDROME 21	0.009804814	0.3678388750377178
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3678388750377178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3678388750377178
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3678388750377178
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3678388750377178
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.3678388750377178
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009804814	0.3678388750377178
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3678388750377178
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3678388750377178
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009804814	0.3678388750377178
JOUBERT SYNDROME 23; JBTS23	0.009804814	0.3678388750377178
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.3678388750377178
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.009800679	0.3676837457565013
HYPOPHOSPHATASIA, INFANTILE	0.009800679	0.3676837457565013
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.3676837457565013
RETT SYNDROME; RTT	0.009800679	0.3676837457565013
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.3676837457565013
TENORIO SYNDROME; TNORS	0.009800679	0.3676837457565013
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.009800679	0.3676837457565013
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.009800679	0.3676837457565013
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.009800679	0.3676837457565013
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.009800679	0.3676837457565013
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.3676837457565013
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.3676837457565013
GLUTAMINE DEFICIENCY, CONGENITAL	0.009800679	0.3676837457565013
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.009800679	0.3676837457565013
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.009746043	0.36563401337233153
DYSTONIA 28, CHILDHOOD-ONSET	0.009554564	0.35845045844172835
BARDET-BIEDL SYNDROME 1; BBS1	0.009554564	0.35845045844172835
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.009554564	0.35845045844172835
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009554564	0.35845045844172835
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.35845045844172835
OKAMOTO SYNDROME	0.009554564	0.35845045844172835
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.009554564	0.35845045844172835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.009554564	0.35845045844172835
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.009554564	0.35845045844172835
9Q33.3Q34.11 MICRODELETION SYNDROME	0.009550429	0.35829532916051193
7Q11.23 MICRODUPLICATION SYNDROME	0.009550429	0.35829532916051193
SANJAD-SAKATI SYNDROME	0.009550429	0.35829532916051193
PITT-HOPKINS SYNDROME	0.009550429	0.35829532916051193
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.009550429	0.35829532916051193
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009524064	0.3573062158595998
PEROXISOME BIOGENESIS DISORDER 6B	0.009524064	0.3573062158595998
PEROXISOME BIOGENESIS DISORDER 5B	0.009524064	0.3573062158595998
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009490333	0.3560407585960661
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3560407585960661
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.3560407585960661
KAGAMI-OGATA SYNDROME	0.009490333	0.3560407585960661
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3560407585960661
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	0.3560407585960661
FG SYNDROME TYPE 1	0.009490333	0.3560407585960661
KAGAMI-OGATA SYNDROME	0.009490333	0.3560407585960661
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3560407585960661
INFANTILE SIALIC ACID STORAGE DISEASE	0.009490333	0.3560407585960661
POSTERIOR CORTICAL ATROPHY	0.00943396	0.3539258606589404
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00943396	0.3539258606589404
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.3539258606589404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.3539258606589404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009383934	0.3520490777273481
COCKAYNE SYNDROME A; CSA	0.009379799	0.35189394844613164
WOLCOTT-RALLISON SYNDROME	0.009379799	0.35189394844613164
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.009351433	0.35082976532860183
WYBURN-MASON SYNDROME	0.009351433	0.35082976532860183
PFEIFFER SYNDROME TYPE 2	0.009351433	0.35082976532860183
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.009351433	0.35082976532860183
SRD5A3-CDG	0.009351433	0.35082976532860183
SEVERE CANAVAN DISEASE	0.009351433	0.35082976532860183
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009351433	0.35082976532860183
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009351433	0.35082976532860183
RAVINE SYNDROME	0.00925926	0.34737178921310885
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.34737178921310885
STUVE-WIEDEMANN SYNDROME	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
AORTIC ARCH DEFECTS	0.00925926	0.34737178921310885
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00925926	0.34737178921310885
MERRF	0.00925926	0.34737178921310885
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00925926	0.34737178921310885
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.34737178921310885
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00925926	0.34737178921310885
SHPRINTZEN-GOLDBERG SYNDROME	0.00925926	0.34737178921310885
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.34737178921310885
BUTYRYLCHOLINESTERASE	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00925926	0.34737178921310885
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 3	0.00925926	0.34737178921310885
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310885
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.34737178921310885
LARYNGOTRACHEAL ANGIOMA	0.00925926	0.34737178921310885
CAMPOMELIC DYSPLASIA	0.00925926	0.34737178921310885
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.344723149006608
CHROMOSOME XP11.3 DELETION SYNDROME	0.009188660000000001	0.344723149006608
SIFRIM-HITZ-WEISS SYNDROME	0.00900901	0.33798337261711947
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.33798337261711947
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.33798337261711947
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00900901	0.33798337261711947
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.33798337261711947
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.33798337261711947
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00900901	0.33798337261711947
ERMINE PHENOTYPE	0.00900901	0.33798337261711947
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.33798337261711947
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.33798337261711947
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.33798337261711947
HYDRANENCEPHALY	0.009005013000000001	0.33783342056463533
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00897851	0.3368391300349909
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.33572880205267364
ROBERTS SYNDROME	0.008948914	0.33572880205267364
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.33572880205267364
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.33572880205267364
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.33557367277145717
ADAMS-OLIVER SYNDROME	0.008944779	0.33557367277145717
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33557367277145717
OLIVER SYNDROME	0.00893619	0.3352514465570997
DUBOWITZ SYNDROME	0.00883838	0.3315819919027392
FONTAINE PROGEROID SYNDROME; FPS	0.00883838	0.3315819919027392
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00883838	0.3315819919027392
16P12.1P12.3 TRIPLICATION SYNDROME	0.00883838	0.3315819919027392
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.008810014	0.33051780878520937
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.008810014	0.33051780878520937
KNOBLOCH SYNDROME 1; KNO1	0.008805878999999999	0.3303626795039929
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.008805878999999999	0.3303626795039929
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.008805878999999999	0.3303626795039929
GLIOBLASTOMA	0.008805878999999999	0.3303626795039929
TYROSINEMIA TYPE 2	0.008805878999999999	0.3303626795039929
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.008805878999999999	0.3303626795039929
NEURONAL CEROID LIPOFUSCINOSIS	0.008805878999999999	0.3303626795039929
ECTODERMAL DYSPLASIA SYNDROME	0.008805878999999999	0.3303626795039929
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.008794863	0.3299494015930183
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.3248549710043302
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00865907	0.3248549710043302
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.3248549710043302
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.3248549710043302
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.3248549710043302
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.3248549710043302
CONE DYSTROPHY 4	0.00865907	0.3248549710043302
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00865907	0.3248549710043302
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00865907	0.3248549710043302
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.3248549710043302
8Q24.3 MICRODELETION SYNDROME	0.008475423	0.31796524256235753
ISOLATED COMPLEX I DEFICIENCY	0.008463594000000001	0.31752146402124287
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3152617162280647
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3152617162280647
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3152617162280647
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.3152617162280647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.3152617162280647
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
NEMALINE MYOPATHY 10	0.00840336	0.3152617162280647
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.3152617162280647
HEC SYNDROME	0.00840336	0.3152617162280647
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.3152617162280647
OMPHALOCELE	0.00840336	0.3152617162280647
RENAL TUBULAR DYSGENESIS	0.00840336	0.3152617162280647
SCHISIS ASSOCIATION	0.00840336	0.3152617162280647
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3152617162280647
FATCO SYNDROME	0.00840336	0.3152617162280647
HYDROLETHALUS	0.00840336	0.3152617162280647
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3152617162280647
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.3152617162280647
TEMPLE SYNDROME	0.00840336	0.3152617162280647
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.3152617162280647
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.3152617162280647
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3152617162280647
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.3152617162280647
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3152617162280647
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.3152617162280647
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3152617162280647
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.3152617162280647
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.3152617162280647
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.3152617162280647
GMS SYNDROME	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3152617162280647
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3152617162280647
EBSTEIN MALFORMATION	0.00840336	0.3152617162280647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.3152617162280647
CONGENITAL ANALBUMINEMIA	0.00840336	0.3152617162280647
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3152617162280647
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
DISTAL MONOSOMY 17Q	0.00840336	0.3152617162280647
BLAU SYNDROME	0.00826446	0.31005072296060043
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.31005072296060043
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.31005072296060043
LEBER OPTIC ATROPHY AND DYSTONIA	0.00826446	0.31005072296060043
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00826446	0.31005072296060043
WEILL-MARCHESANI SYNDROME	0.00826446	0.31005072296060043
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.31005072296060043
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.31005072296060043
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.31005072296060043
ISOLATED ANIRIDIA	0.00826446	0.31005072296060043
X-LINKED CORNEAL DERMOID	0.00826446	0.31005072296060043
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00826446	0.31005072296060043
VON HIPPEL-LINDAU DISEASE	0.00826446	0.31005072296060043
BRITTLE CORNEA SYNDROME	0.00826446	0.31005072296060043
SPONDYLO-OCULAR SYNDROME	0.00826446	0.31005072296060043
CONGENITAL GLAUCOMA	0.00826446	0.31005072296060043
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.31005072296060043
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.31005072296060043
NEUROMYELITIS OPTICA	0.00826446	0.31005072296060043
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00826446	0.31005072296060043
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00826446	0.31005072296060043
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.31005072296060043
STICKLER SYNDROME TYPE 1	0.00826446	0.31005072296060043
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00826446	0.31005072296060043
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.31005072296060043
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.31005072296060043
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.31005072296060043
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00826446	0.31005072296060043
LCAT DEFICIENCY	0.00826446	0.31005072296060043
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00826446	0.31005072296060043
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.31005072296060043
CUSHING DISEASE	0.00826446	0.31005072296060043
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.31005072296060043
CATARACT 44; CTRCT44	0.00826446	0.31005072296060043
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.31005072296060043
NANCE-HORAN SYNDROME	0.00826446	0.31005072296060043
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.31005072296060043
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.31005072296060043
NANCE-HORAN SYNDROME	0.00826446	0.31005072296060043
SUSAC SYNDROME	0.00826446	0.31005072296060043
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.31005072296060043
15Q OVERGROWTH SYNDROME	0.008249309	0.30948231576840934
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.008249309	0.30948231576840934
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008249309	0.30948231576840934
DILATED CARDIOMYOPATHY WITH ATAXIA	0.008249309	0.30948231576840934
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.008031413	0.30130769669708185
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.008031413	0.30130769669708185
MAN1B1-CDG	0.008031413	0.30130769669708185
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.008031413	0.30130769669708185
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.008031413	0.30130769669708185
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.008031413	0.30130769669708185
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00770789	0.2891703592250168
TRISOMY 18P	0.00770789	0.2891703592250168
W SYNDROME	0.007587804	0.2846651948080499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2846651948080499
1Q44 MICRODELETION SYNDROME	0.007587804	0.2846651948080499
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2846651948080499
PELGER-HUET ANOMALY; PHA	0.007587804	0.2846651948080499
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2846651948080499
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2846651948080499
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2846651948080499
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2846651948080499
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
JOUBERT SYNDROME 24	0.007489994	0.2809957401536894
AARSKOG-SCOTT SYNDROME	0.007489994	0.2809957401536894
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007489994	0.2809957401536894
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.007489994	0.2809957401536894
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007489994	0.2809957401536894
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.007489994	0.2809957401536894
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007489994	0.2809957401536894
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.007489994	0.2809957401536894
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007489994	0.2809957401536894
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.007489994	0.2809957401536894
COFFIN-SIRIS SYNDROME 7; CSS7	0.007489994	0.2809957401536894
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007489994	0.2809957401536894
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.007489994	0.2809957401536894
XP22.13P22.2 DUPLICATION SYNDROME	0.007485858999999999	0.2808406108724729
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.007485858999999999	0.2808406108724729
IMMUNODEFICIENCY 47	0.007485858999999999	0.2808406108724729
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.007485858999999999	0.2808406108724729
MENTAL RETARDATION, X-LINKED 1	0.007485858999999999	0.2808406108724729
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007485858999999999	0.2808406108724729
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007485858999999999	0.2808406108724729
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.007111073000000001	0.2667800829909766
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.007111073000000001	0.2667800829909766
WEBB-DATTANI SYNDROME; WEDAS	0.007111073000000001	0.2667800829909766
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007111073000000001	0.2667800829909766
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.007111073000000001	0.2667800829909766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007111073000000001	0.2667800829909766
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.007111073000000001	0.2667800829909766
GM2-GANGLIOSIDOSIS, AB VARIANT	0.007111073000000001	0.2667800829909766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007111073000000001	0.2667800829909766
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.007111073000000001	0.2667800829909766
CANAVAN DISEASE	0.007111073000000001	0.2667800829909766
TAY-SACHS DISEASE	0.007111073000000001	0.2667800829909766
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.007111073000000001	0.2667800829909766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.007111073000000001	0.2667800829909766
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.264198108983441
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.264198108983441
AMISH LETHAL MICROCEPHALY	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.264198108983441
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.264198108983441
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.264198108983441
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00694444	0.26052865432908046
9P13 MICRODELETION SYNDROME	0.00694444	0.26052865432908046
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00694444	0.26052865432908046
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00694444	0.26052865432908046
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00694444	0.26052865432908046
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00694444	0.26052865432908046
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00694444	0.26052865432908046
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00694444	0.26052865432908046
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00694444	0.26052865432908046
BRACHYDACTYLY, TYPE B2	0.00694444	0.26052865432908046
CRANIOECTODERMAL DYSPLASIA 4	0.00694444	0.26052865432908046
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00694444	0.26052865432908046
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00694444	0.26052865432908046
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.26052865432908046
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00694444	0.26052865432908046
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00694444	0.26052865432908046
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00694444	0.26052865432908046
FLOATING-HARBOR SYNDROME	0.00694444	0.26052865432908046
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00694444	0.26052865432908046
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00694444	0.26052865432908046
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00694444	0.26052865432908046
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00694444	0.26052865432908046
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00694444	0.26052865432908046
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006900923	0.2588960640193595
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.006900923	0.2588960640193595
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006900923	0.2588960640193595
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.006900923	0.2588960640193595
XQ28 (MECP2) DUPLICATION	0.006900923	0.2588960640193595
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006900923	0.2588960640193595
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006900923	0.2588960640193595
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.006900923	0.2588960640193595
MONOSOMY 18Q	0.006900923	0.2588960640193595
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006900923	0.2588960640193595
TETRASOMY 5P	0.006900923	0.2588960640193595
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.006900923	0.2588960640193595
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.006900923	0.2588960640193595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.006900923	0.2588960640193595
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.006581483000000001	0.24691190498869883
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006581483000000001	0.24691190498869883
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.006581483000000001	0.24691190498869883
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.006581483	0.24691190498869878
LIGNEOUS CONJUNCTIVITIS	0.006569654000000001	0.24646812644758412
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006569654000000001	0.24646812644758412
JOUBERT SYNDROME 6	0.006569654000000001	0.24646812644758412
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.006569654000000001	0.24646812644758412
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.006569654000000001	0.24646812644758412
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006569654000000001	0.24646812644758412
ARIMA SYNDROME	0.006569654000000001	0.24646812644758412
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006569654000000001	0.24646812644758412
SANDHOFF DISEASE	0.0065655190000000006	0.24631299716636768
MOMO SYNDROME	0.0065655190000000006	0.24631299716636768
KRABBE DISEASE	0.0065655190000000006	0.24631299716636768
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0065655190000000006	0.24631299716636768
BEHÃ‡ET DISEASE	0.0065655190000000006	0.24631299716636768
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0065655190000000006	0.24631299716636768
NORRIE DISEASE	0.0065655190000000006	0.24631299716636768
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0065655190000000006	0.24631299716636768
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.0065655190000000006	0.24631299716636768
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0065655190000000006	0.24631299716636768
TAY-SACHS DISEASE; TSD	0.0065655190000000006	0.24631299716636768
GM1 GANGLIOSIDOSIS	0.0065655190000000006	0.24631299716636768
MICROPHTHALMIA, SYNDROMIC 1	0.0065655190000000006	0.24631299716636768
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0065655190000000006	0.24631299716636768
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.006359504	0.23858410747596703
HYPOTONIA-CYSTINURIA SYNDROME	0.006359504	0.23858410747596703
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006359504	0.23858410747596703
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.006359504	0.23858410747596703
HARTSFIELD SYNDROME; HRTFDS	0.006359504	0.23858410747596703
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.006359504	0.23858410747596703
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.006359504	0.23858410747596703
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.006359504	0.23858410747596703
ALAZAMI-YUAN SYNDROME	0.006359504	0.23858410747596703
ZEBRA BODY MYOPATHY	0.006359504	0.23858410747596703
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.006359504	0.23858410747596703
47,XYY SYNDROME	0.006355369	0.2384289781947506
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006355369	0.2384289781947506
1Q41Q42 MICRODELETION SYNDROME	0.006355369	0.2384289781947506
MALAN OVERGROWTH SYNDROME	0.006355369	0.2384289781947506
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.006355369	0.2384289781947506
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006355369	0.2384289781947506
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.006355369	0.2384289781947506
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.006355369	0.2384289781947506
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.006355369	0.2384289781947506
RETT SYNDROME, CONGENITAL VARIANT	0.006355369	0.2384289781947506
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.006145473	0.23055448832529293
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.006145473	0.23055448832529293
COFFIN-SIRIS SYNDROME 4; CSS4	0.006145473	0.23055448832529293
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006145473	0.23055448832529293
COFFIN-SIRIS SYNDROME 3; CSS3	0.006145473	0.23055448832529293
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.006145473	0.23055448832529293
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.006040064	0.22659994844530634
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006040064	0.22659994844530634
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.006040064	0.22659994844530634
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.006040064	0.22659994844530634
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.006040064	0.22659994844530634
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006035929000000001	0.2264448191640899
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006035929000000001	0.2264448191640899
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006035929000000001	0.2264448191640899
EPISODIC ATAXIA TYPE 6	0.006035929000000001	0.2264448191640899
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.006035929000000001	0.2264448191640899
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.006035929000000001	0.2264448191640899
20P13 MICRODELETION SYNDROME	0.006035929000000001	0.2264448191640899
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.22600104062297519
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.22600104062297519
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.22600104062297519
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.22600104062297519
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.22600104062297519
WEILL-MARCHESANI SYNDROME 1; WMS1	0.006024100000000001	0.22600104062297519
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.006024100000000001	0.22600104062297519
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.22600104062297519
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.22600104062297519
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006024100000000001	0.22600104062297519
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.22600104062297519
MUSK, INABILITY TO SMELL	0.006024100000000001	0.22600104062297519
CYSTINOSIS, NEPHROPATHIC; CTNS	0.006024100000000001	0.22600104062297519
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.22600104062297519
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.22600104062297519
EHLERS-DANLOS SYNDROME, TYPE VI	0.006024100000000001	0.22600104062297519
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.22600104062297519
FLECK RETINA OF KANDORI	0.006024100000000001	0.22600104062297519
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.22600104062297519
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.22600104062297519
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.22600104062297519
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.22600104062297519
FRASER SYNDROME	0.006024100000000001	0.22600104062297519
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.22600104062297519
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.22600104062297519
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.006024100000000001	0.22600104062297519
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.006024100000000001	0.22600104062297519
ALBERS-SCHÃ–NBERG OSTEOPETROSIS	0.006024100000000001	0.22600104062297519
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.006024100000000001	0.22600104062297519
SANDHOFF DISEASE	0.006024100000000001	0.22600104062297519
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.22600104062297519
RODRIGUES BLINDNESS	0.006024100000000001	0.22600104062297519
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.006024100000000001	0.22600104062297519
TEMPORAL ARTERITIS	0.006024100000000001	0.22600104062297519
VITREORETINOCHOROIDOPATHY; VRCP	0.006024100000000001	0.22600104062297519
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.22600104062297519
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.22600104062297519
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.22600104062297519
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.22600104062297519
LEBER CONGENITAL AMAUROSIS, TYPE I	0.006024100000000001	0.22600104062297519
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.22600104062297519
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.22600104062297519
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.006024100000000001	0.22600104062297519
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.006024100000000001	0.22600104062297519
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.22600104062297519
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.22600104062297519
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.22600104062297519
COGAN SYNDROME	0.006024100000000001	0.22600104062297519
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.22600104062297519
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.22600104062297519
WEILL-MARCHESANI SYNDROME 2; WMS2	0.006024100000000001	0.22600104062297519
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.006024100000000001	0.22600104062297519
CEREBROOCULONASAL SYNDROME	0.006024100000000001	0.22600104062297519
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.22600104062297519
RETINITIS PIGMENTOSA	0.006024100000000001	0.22600104062297519
PIERSON SYNDROME	0.006024100000000001	0.22600104062297519
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.006024100000000001	0.22600104062297519
SARCOIDOSIS	0.006024100000000001	0.22600104062297519
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.22600104062297519
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.006024100000000001	0.22600104062297519
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.22600104062297519
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00581395	0.2181170216513581
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00581395	0.2181170216513581
GERMAN SYNDROME	0.00581395	0.2181170216513581
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00581395	0.2181170216513581
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00581395	0.2181170216513581
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00581395	0.2181170216513581
EMERY-NELSON SYNDROME	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.2181170216513581
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00581395	0.2181170216513581
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00581395	0.2181170216513581
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00581395	0.2181170216513581
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00581395	0.2181170216513581
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00581395	0.2181170216513581
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00581395	0.2181170216513581
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00581395	0.2181170216513581
FG SYNDROME 2; FGS2	0.00581395	0.2181170216513581
LOEYS-DIETZ SYNDROME 5	0.00581395	0.2181170216513581
BETHLEM MYOPATHY	0.00581395	0.2181170216513581
AMISH NEMALINE MYOPATHY	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00581395	0.2181170216513581
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00581395	0.2181170216513581
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00581395	0.2181170216513581
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00581395	0.2181170216513581
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00581395	0.2181170216513581
TYPICAL NEMALINE MYOPATHY	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00581395	0.2181170216513581
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00581395	0.2181170216513581
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00581395	0.2181170216513581
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00581395	0.2181170216513581
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00581395	0.2181170216513581
RADICULONEUROPATHY, FATAL NEONATAL	0.00581395	0.2181170216513581
MYOPATHY AND DIABETES MELLITUS	0.00581395	0.2181170216513581
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00581395	0.2181170216513581
BETHLEM MYOPATHY 1	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00581395	0.2181170216513581
NEMALINE MYOPATHY 3; NEM3	0.00581395	0.2181170216513581
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00581395	0.2181170216513581
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00581395	0.2181170216513581
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00581395	0.2181170216513581
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.005604054	0.21024253178190044
PETERS PLUS SYNDROME	0.005604054	0.21024253178190044
2P15P16.1 MICRODELETION SYNDROME	0.005604054	0.21024253178190044
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005604054	0.21024253178190044
FILIPPI SYNDROME; FLPIS	0.005599919	0.210087402500684
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.005599919	0.210087402500684
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.005599919	0.210087402500684
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.005599919	0.210087402500684
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.005599919	0.210087402500684
COFS SYNDROME	0.005599919	0.210087402500684
CONGENITAL RUBELLA SYNDROME	0.005599919	0.210087402500684
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.005599919	0.210087402500684
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.2061328626206974
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.2061328626206974
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00549451	0.2061328626206974
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.2061328626206974
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00549451	0.2061328626206974
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00549451	0.2061328626206974
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.2061328626206974
SPINOCEREBELLAR ATAXIA TYPE 25	0.00549451	0.2061328626206974
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.2061328626206974
INTERMEDIATE UVEITIS	0.00549451	0.2061328626206974
IRVAN SYNDROME	0.00549451	0.2061328626206974
STARGARDT DISEASE 3; STGD3	0.00549451	0.2061328626206974
MADRAS MOTOR NEURON DISEASE	0.00549451	0.2061328626206974
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.2061328626206974
KERATOCONUS 9; KTCN9	0.00549451	0.2061328626206974
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.2061328626206974
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00549451	0.2061328626206974
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.2061328626206974
COLOBOMA, OCULAR	0.00549451	0.2061328626206974
PRIMARY HYPEROXALURIA	0.00549451	0.2061328626206974
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00549451	0.2061328626206974
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00549451	0.2061328626206974
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00549451	0.2061328626206974
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.2061328626206974
FOCAL DERMAL HYPOPLASIA; FDH	0.00549451	0.2061328626206974
DERMOCHONDROCORNEAL DYSTROPHY	0.00549451	0.2061328626206974
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.2061328626206974
FRIEDREICH ATAXIA	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.2061328626206974
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.2061328626206974
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00549451	0.2061328626206974
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.2061328626206974
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.2061328626206974
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.2061328626206974
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.2061328626206974
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.2061328626206974
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.2061328626206974
RETINOBLASTOMA	0.00549451	0.2061328626206974
NANOPHTHALMOS 4; NNO4	0.00549451	0.2061328626206974
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00549451	0.2061328626206974
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.2061328626206974
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.2061328626206974
RAMOS-ARROYO SYNDROME	0.00549451	0.2061328626206974
LEBER CONGENITAL AMAUROSIS 16	0.00549451	0.2061328626206974
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.2061328626206974
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.2061328626206974
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.2061328626206974
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.2061328626206974
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.2061328626206974
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00549451	0.2061328626206974
FOVEAL HYPOPLASIA 2; FVH2	0.00549451	0.2061328626206974
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.2061328626206974
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0050585	0.1897754459572915
OSTEOGENESIS IMPERFECTA	0.0050585	0.1897754459572915
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.004251533	0.15950115075163418
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004251533	0.15950115075163418
COFFIN-SIRIS SYNDROME 2; CSS2	0.004251533	0.15950115075163418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004251533	0.15950115075163418
INCONTINENTIA PIGMENTI	0.004251533	0.15950115075163418
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.15950115075163418
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.15950115075163418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004251533	0.15950115075163418
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004251533	0.15950115075163418
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.15950115075163418
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.15950115075163418
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004251533	0.15950115075163418
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.15950115075163418
RFT1-CDG	0.004251533	0.15950115075163418
JABERI-ELAHI SYNDROME; JABELS	0.004251533	0.15950115075163418
HEART AND BRAIN MALFORMATION SYNDROME	0.004251533	0.15950115075163418
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.15950115075163418
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004251533	0.15950115075163418
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004251533	0.15950115075163418
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.15950115075163418
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.004251533	0.15950115075163418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.15950115075163418
CRANIOTELENCEPHALIC DYSPLASIA	0.0037101139999999996	0.1391891942082417
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0037101139999999996	0.1391891942082417
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.1391891942082417
TREACHER-COLLINS SYNDROME	0.0037101139999999996	0.1391891942082417
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0037101139999999996	0.1391891942082417
HYPERTRYPTOPHANEMIA; HYPTRP	0.0037101139999999996	0.1391891942082417
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.1391891942082417
N SYNDROME	0.0037101139999999996	0.1391891942082417
ABLEPHARON MACROSTOMIA SYNDROME	0.0037101139999999996	0.1391891942082417
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.1391891942082417
MUCOLIPIDOSIS IV; ML4	0.0037101139999999996	0.1391891942082417
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0037101139999999996	0.1391891942082417
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.1391891942082417
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13903406492702525
TRIPLE A SYNDROME	0.003705979	0.13903406492702525
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003705979	0.13903406492702525
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003705979	0.13903406492702525
MUSCLE-EYE-BRAIN DISEASE	0.003705979	0.13903406492702525
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003705979	0.13903406492702525
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.003705979	0.13903406492702525
PAPILLOMA OF CHOROID PLEXUS	0.003705979	0.13903406492702525
INFANTILE NEUROAXONAL DYSTROPHY	0.003705979	0.13903406492702525
NEONATAL ADRENOLEUKODYSTROPHY	0.003705979	0.13903406492702525
CADASIL	0.003705979	0.13903406492702525
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.003705979	0.13903406492702525
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.003705979	0.13903406492702525
FOUNTAIN SYNDROME	0.003705979	0.13903406492702525
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13903406492702525
FLYNN-AIRD SYNDROME	0.003705979	0.13903406492702525
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13903406492702525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.003705979	0.13903406492702525
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.003705979	0.13903406492702525
KALLMANN SYNDROME	0.003705979	0.13903406492702525
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.003705979	0.13903406492702525
ERDHEIM-CHESTER DISEASE	0.00316456	0.11872210838363279
MALT LYMPHOMA	0.00316456	0.11872210838363279
BLUE CONE MONOCHROMATISM	0.00316456	0.11872210838363279
X-LINKED RETINAL DYSPLASIA	0.00316456	0.11872210838363279
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11872210838363279
CONE ROD DYSTROPHY	0.00316456	0.11872210838363279
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11872210838363279
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11872210838363279
FISH-EYE DISEASE	0.00316456	0.11872210838363279
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11872210838363279
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11872210838363279
BRADYOPSIA	0.00316456	0.11872210838363279
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11872210838363279
PROLIDASE DEFICIENCY	0.00316456	0.11872210838363279
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11872210838363279
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.11872210838363279
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11872210838363279
GOLDENHAR SYNDROME	0.00316456	0.11872210838363279
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11872210838363279
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00316456	0.11872210838363279
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.11872210838363279
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11872210838363279
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11872210838363279
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11872210838363279
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11872210838363279
ALBINISM, OCULAR, TYPE I	0.00316456	0.11872210838363279
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.11872210838363279
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.11872210838363279
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00316456	0.11872210838363279
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11872210838363279
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11872210838363279
JALILI SYNDROME	0.00316456	0.11872210838363279
MARFAN SYNDROME	0.00316456	0.11872210838363279
TANGIER DISEASE; TGD	0.00316456	0.11872210838363279
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11872210838363279
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.11872210838363279
MANGANESE POISONING	0.00316456	0.11872210838363279
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.11872210838363279
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.11872210838363279
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363279
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11872210838363279
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.11872210838363279
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11872210838363279
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00316456	0.11872210838363279
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.11872210838363279
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363279
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363279
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11872210838363279
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11872210838363279
CHYLOMICRON RETENTION DISEASE	0.00316456	0.11872210838363279
CYSTINOSIS	0.00316456	0.11872210838363279
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11872210838363279
APERT SYNDROME	0.00316456	0.11872210838363279
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.11872210838363279
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.11872210838363279
MOEBIUS SYNDROME	0.00316456	0.11872210838363279
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00316456	0.11872210838363279
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363279
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11872210838363279
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11872210838363279
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11872210838363279
N SYNDROME	0.00316456	0.11872210838363279
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00316456	0.11872210838363279
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11872210838363279
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00316456	0.11872210838363279
ASCHER SYNDROME	0.00316456	0.11872210838363279
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.11872210838363279
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.11872210838363279
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.11872210838363279
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.11872210838363279
BETA-THALASSEMIA MAJOR	0.00316456	0.11872210838363279
WAGR SYNDROME	0.00316456	0.11872210838363279
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00316456	0.11872210838363279
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11872210838363279
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.11872210838363279
MUCOLIPIDOSIS TYPE III	0.00316456	0.11872210838363279
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11872210838363279
HALLERMANN-STREIFF SYNDROME	0.00316456	0.11872210838363279
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363279
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.11872210838363279
RENAL COLOBOMA SYNDROME	0.00316456	0.11872210838363279
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11872210838363279
MMEP SYNDROME	0.00316456	0.11872210838363279
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.11872210838363279
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.11872210838363279
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11872210838363279
FETAL METHYLMERCURY SYNDROME	0.00316456	0.11872210838363279
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.11872210838363279
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11872210838363279
GILLESPIE SYNDROME; GLSP	0.00316456	0.11872210838363279
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11872210838363279
GÃ“MEZ-LÃ“PEZ-HERNÃNDEZ SYNDROME	0.00316456	0.11872210838363279
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11872210838363279
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11872210838363279
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11872210838363279
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11872210838363279
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11872210838363279
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.11872210838363279
GAPO SYNDROME	0.00316456	0.11872210838363279
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11872210838363279
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11872210838363279
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11872210838363279
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11872210838363279
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11872210838363279
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11872210838363279
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.11872210838363279
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11872210838363279
ABETALIPOPROTEINEMIA	0.00316456	0.11872210838363279
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11872210838363279
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.11872210838363279
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002980913	0.11183237994166013
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.002980913	0.11183237994166013
EMANUEL SYNDROME	0.002980913	0.11183237994166013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002980913	0.11183237994166013
LATHOSTEROLOSIS	0.002980913	0.11183237994166013
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002980913	0.11183237994166013
DISTAL MONOSOMY 15Q	0.002980913	0.11183237994166013
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002980913	0.11183237994166013
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002980913	0.11183237994166013
PALLISTER-HALL SYNDROME	0.002980913	0.11183237994166013
COFFIN-SIRIS SYNDROME	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002980913	0.11183237994166013
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002980913	0.11183237994166013
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002980913	0.11183237994166013
AL KAISSI SYNDROME; ALKAS	0.002980913	0.11183237994166013
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002980913	0.11183237994166013
BOHRING-OPITZ SYNDROME	0.002980913	0.11183237994166013
8P23.1 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
CATEL-MANZKE SYNDROME; CATMANS	0.002980913	0.11183237994166013
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.002980913	0.11183237994166013
COHEN SYNDROME	0.002980913	0.11183237994166013
WOLF-HIRSCHHORN SYNDROME	0.002980913	0.11183237994166013
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.002980913	0.11183237994166013
AICARDI-GOUTIERES SYNDROME 7	0.002980913	0.11183237994166013
15Q24 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
PETERS-PLUS SYNDROME; PTRPLS	0.002980913	0.11183237994166013
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002980913	0.11183237994166013
COFFIN-SIRIS SYNDROME 5	0.002980913	0.11183237994166013
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002980913	0.11183237994166013
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002980913	0.11183237994166013
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002980913	0.11183237994166013
FILIPPI SYNDROME	0.002980913	0.11183237994166013
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002980913	0.11183237994166013
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002980913	0.11183237994166013
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002980913	0.11183237994166013
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.002980913	0.11183237994166013
MATERNAL PHENYLKETONURIA	0.002980913	0.11183237994166013
22Q11.2 DELETION SYNDROME	0.002980913	0.11183237994166013
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002980913	0.11183237994166013
SMITH-LEMLI-OPITZ SYNDROME	0.002980913	0.11183237994166013
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002980913	0.11183237994166013
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.002980913	0.11183237994166013
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002980913	0.11183237994166013
RUVALCABA SYNDROME	0.002980913	0.11183237994166013
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002980913	0.11183237994166013
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002980913	0.11183237994166013
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.002980913	0.11183237994166013
BOHRING-OPITZ SYNDROME	0.002980913	0.11183237994166013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002980913	0.11183237994166013
MACDERMOT-WINTER SYNDROME	0.002980913	0.11183237994166013
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002980913	0.11183237994166013
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002980913	0.11183237994166013
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.002980913	0.11183237994166013
STT3B-CDG	0.002980913	0.11183237994166013
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002980913	0.11183237994166013
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002980913	0.11183237994166013
19P13.12 MICRODELETION SYNDROME	0.002980913	0.11183237994166013
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.002439494	0.09152042339826766
DE BARSY SYNDROME	0.002439494	0.09152042339826766
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002439494	0.09152042339826766
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002439494	0.09152042339826766
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.002439494	0.09152042339826766
RITSCHER-SCHINZEL SYNDROME 1	0.002439494	0.09152042339826766
TRISOMY 17P	0.002439494	0.09152042339826766
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.002439494	0.09152042339826766
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.002439494	0.09152042339826766
XQ27.3Q28 DUPLICATION SYNDROME	0.002439494	0.09152042339826766
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002439494	0.09152042339826766
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002439494	0.09152042339826766
DIAPHANOSPONDYLODYSOSTOSIS	0.002439494	0.09152042339826766
OROFACIODIGITAL SYNDROME TYPE 4	0.002439494	0.09152042339826766
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.002439494	0.09152042339826766
EAR-PATELLA-SHORT STATURE SYNDROME	0.002439494	0.09152042339826766
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002439494	0.09152042339826766
12Q14 MICRODELETION SYNDROME	0.002439494	0.09152042339826766
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.002439494	0.09152042339826766
SECKEL SYNDROME 9; SCKL9	0.002439494	0.09152042339826766
LOWRY-MACLEAN SYNDROME	0.002439494	0.09152042339826766
OCULO-PALATO-CEREBRAL SYNDROME	0.002439494	0.09152042339826766
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.002439494	0.09152042339826766
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002439494	0.09152042339826766
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.002439494	0.09152042339826766
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002439494	0.09152042339826766
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002439494	0.09152042339826766
MARDEN-WALKER SYNDROME	0.002439494	0.09152042339826766
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002439494	0.09152042339826766
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002439494	0.09152042339826766
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002439494	0.09152042339826766
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002439494	0.09152042339826766
CONGENITAL VARICELLA SYNDROME	0.002439494	0.09152042339826766
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002439494	0.09152042339826766
TARP SYNDROME; TARPS	0.002439494	0.09152042339826766
%300712 CRANIOFACIOSKELETAL SYNDROME	0.002439494	0.09152042339826766
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.002439494	0.09152042339826766
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.002439494	0.09152042339826766
20Q11.2 MICRODELETION SYNDROME	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.002439494	0.09152042339826766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.002439494	0.09152042339826766
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.002439494	0.09152042339826766
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002439494	0.09152042339826766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.002439494	0.09152042339826766
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.002439494	0.09152042339826766
FETAL ALCOHOL SYNDROME	0.002439494	0.09152042339826766
FETAL TRIMETHADIONE SYNDROME	0.002439494	0.09152042339826766
FETAL HYDANTOIN SYNDROME	0.002439494	0.09152042339826766
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002439494	0.09152042339826766
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.002439494	0.09152042339826766
DYSKERATOSIS CONGENITA	0.002439494	0.09152042339826766
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.002439494	0.09152042339826766
DISTAL TRISOMY 6P	0.002439494	0.09152042339826766
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.002439494	0.09152042339826766
SILVER-RUSSELL SYNDROME; SRS	0.002439494	0.09152042339826766
REVESZ SYNDROME	0.002439494	0.09152042339826766
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002439494	0.09152042339826766
WARSAW BREAKAGE SYNDROME; WABS	0.002439494	0.09152042339826766
BRESEK SYNDROME	0.002439494	0.09152042339826766
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002439494	0.09152042339826766
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.002439494	0.09152042339826766
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.002439494	0.09152042339826766
SAUL-WILSON SYNDROME; SWILS	0.002439494	0.09152042339826766
TRISOMY 18	0.002439494	0.09152042339826766
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002439494	0.09152042339826766
COLE-CARPENTER SYNDROME	0.002439494	0.09152042339826766
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002439494	0.09152042339826766
FLOATING-HARBOR SYNDROME	0.002439494	0.09152042339826766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.002439494	0.09152042339826766
HOYERAAL-HREIDARSSON SYNDROME	0.002439494	0.09152042339826766
RABSON-MENDENHALL SYNDROME	0.002439494	0.09152042339826766
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.002439494	0.09152042339826766
MOSAIC TRISOMY 9	0.002439494	0.09152042339826766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002439494	0.09152042339826766
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002439494	0.09152042339826766
CUTIS LAXA	0.002439494	0.09152042339826766
GABRIELE-DE VRIES SYNDROME; GADEVS	0.002439494	0.09152042339826766
SYNDROMIC DIARRHEA	0.002439494	0.09152042339826766
DISTAL TRISOMY 15Q	0.002435359	0.0913652941170512
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.002435359	0.0913652941170512
4Q21 MICRODELETION SYNDROME	0.002435359	0.0913652941170512
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.002435359	0.0913652941170512
THANATOPHORIC DYSPLASIA	0.002435359	0.0913652941170512
DISTAL MONOSOMY 3P	0.002435359	0.0913652941170512
BRANCHIOOCULOFACIAL SYNDROME	0.002435359	0.0913652941170512
KAPUR-TORIELLO SYNDROME	0.002435359	0.0913652941170512
WIEDEMANN-STEINER SYNDROME	0.002435359	0.0913652941170512
HARROD SYNDROME	0.002435359	0.0913652941170512
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002435359	0.0913652941170512
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.002435359	0.0913652941170512
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.002435359	0.0913652941170512
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.002435359	0.0913652941170512
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002435359	0.0913652941170512
MARDEN-WALKER SYNDROME	0.002435359	0.0913652941170512
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002435359	0.0913652941170512
3-HYDROXYISOBUTYRIC ACIDURIA	0.002435359	0.0913652941170512
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.002435359	0.0913652941170512
DUBOWITZ SYNDROME	0.002435359	0.0913652941170512
RING CHROMOSOME 10 SYNDROME	0.002435359	0.0913652941170512
ACROCARDIOFACIAL SYNDROME	0.002435359	0.0913652941170512
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002435359	0.0913652941170512
BANGSTAD SYNDROME	0.002435359	0.0913652941170512
SECKEL SYNDROME 1; SCKL1	0.002435359	0.0913652941170512
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.002435359	0.0913652941170512
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002435359	0.0913652941170512
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.002435359	0.0913652941170512
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.002435359	0.0913652941170512
MENKES DISEASE	0.002435359	0.0913652941170512
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002435359	0.0913652941170512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002435359	0.0913652941170512
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.002435359	0.0913652941170512
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.002435359	0.0913652941170512
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.002435359	0.0913652941170512
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002435359	0.0913652941170512
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002435359	0.0913652941170512
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002435359	0.0913652941170512
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002435359	0.0913652941170512
RETINITIS PIGMENTOSA 59; RP59	0.002435359	0.0913652941170512
SECKEL SYNDROME 7; SCKL7	0.002435359	0.0913652941170512
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002435359	0.0913652941170512
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.002435359	0.0913652941170512
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002435359	0.0913652941170512
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00189394	0.07105333757365873
CAT-EYE SYNDROME	0.00189394	0.07105333757365873
NIJMEGEN BREAKAGE SYNDROME	0.00189394	0.07105333757365873
MONOSOMY 13Q14	0.00189394	0.07105333757365873
JUBERG-HAYWARD SYNDROME	0.00189394	0.07105333757365873
DISTAL MONOSOMY 10P	0.00189394	0.07105333757365873
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00189394	0.07105333757365873
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00189394	0.07105333757365873
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00189394	0.07105333757365873
MARTINEZ-FRIAS SYNDROME	0.00189394	0.07105333757365873
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00189394	0.07105333757365873
BARTSOCAS-PAPAS SYNDROME; BPS	0.00189394	0.07105333757365873
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00189394	0.07105333757365873
ENG-STROM SYNDROME	0.00189394	0.07105333757365873
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00189394	0.07105333757365873
ALAGILLE SYNDROME	0.00189394	0.07105333757365873
MONOSOMY 5P	0.00189394	0.07105333757365873
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.00189394	0.07105333757365873
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00189394	0.07105333757365873
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00189394	0.07105333757365873
LAMBOTTE SYNDROME	0.00189394	0.07105333757365873
HYDROLETHALUS SYNDROME 1	0.00189394	0.07105333757365873
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00189394	0.07105333757365873
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00189394	0.07105333757365873
NEU-LAXOVA SYNDROME 2; NLS2	0.00189394	0.07105333757365873
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00189394	0.07105333757365873
MEIER-GORLIN SYNDROME 8; MGORS8	0.00189394	0.07105333757365873
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.00189394	0.07105333757365873
CRANE-HEISE SYNDROME	0.00189394	0.07105333757365873
MULIBREY NANISM	0.00189394	0.07105333757365873
PROGEROID SYNDROME, PETTY TYPE	0.00189394	0.07105333757365873
TETRAPLOIDY	0.00189394	0.07105333757365873
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00189394	0.07105333757365873
ROIFMAN SYNDROME	0.00189394	0.07105333757365873
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00189394	0.07105333757365873
TETRALOGY OF FALLOT	0.00189394	0.07105333757365873
MODY	0.00189394	0.07105333757365873
JOHANSON-BLIZZARD SYNDROME	0.00189394	0.07105333757365873
RUSSELL-SILVER SYNDROME, X-LINKED	0.00189394	0.07105333757365873
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00189394	0.07105333757365873
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00189394	0.07105333757365873
SHORT SYNDROME	0.00189394	0.07105333757365873
FETAL AKINESIA DEFORMATION SEQUENCE	0.00189394	0.07105333757365873
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00189394	0.07105333757365873
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00189394	0.07105333757365873
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00189394	0.07105333757365873
IMMUNODEFICIENCY 55; IMD55	0.00189394	0.07105333757365873
MOSAIC MONOSOMY X	0.00189394	0.07105333757365873
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00189394	0.07105333757365873
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00189394	0.07105333757365873
SECKEL SYNDROME	0.00189394	0.07105333757365873
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00189394	0.07105333757365873
THAKKER-DONNAI SYNDROME	0.00189394	0.07105333757365873
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00189394	0.07105333757365873
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00189394	0.07105333757365873
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00189394	0.07105333757365873
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00189394	0.07105333757365873
ACRORENAL-MANDIBULAR SYNDROME	0.00189394	0.07105333757365873
ACROFACIAL DYSOSTOSIS, RODRÃGUEZ TYPE	0.00189394	0.07105333757365873
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.07105333757365873
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00189394	0.07105333757365873
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00189394	0.07105333757365873
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00189394	0.07105333757365873
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00189394	0.07105333757365873
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00189394	0.07105333757365873
MEIER-GORLIN SYNDROME 1; MGORS1	0.00189394	0.07105333757365873
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00189394	0.07105333757365873
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00189394	0.07105333757365873
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00189394	0.07105333757365873
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00189394	0.07105333757365873
MECKEL SYNDROME, TYPE 1; MKS1	0.00189394	0.07105333757365873
MONOSOMY X	0.00189394	0.07105333757365873
MEIER-GORLIN SYNDROME 5; MGORS5	0.00189394	0.07105333757365873
RESTRICTIVE DERMOPATHY	0.00189394	0.07105333757365873
MECKEL SYNDROME, TYPE 4; MKS4	0.00189394	0.07105333757365873
VERVERI-BRADY SYNDROME; VERBRAS	0.00189394	0.07105333757365873
MEIER-GORLIN SYNDROME 3; MGORS3	0.00189394	0.07105333757365873
BRADDOCK SYNDROME	0.00189394	0.07105333757365873
METHIMAZOLE EMBRYOFETOPATHY	0.00189394	0.07105333757365873
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00189394	0.07105333757365873
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00189394	0.07105333757365873
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00189394	0.07105333757365873
DIASTROPHIC DWARFISM	0.00189394	0.07105333757365873
STIMMLER SYNDROME	0.00189394	0.07105333757365873
TRICHOHEPATOENTERIC SYNDROME 1	0.00189394	0.07105333757365873
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00189394	0.07105333757365873
MEIER-GORLIN SYNDROME 2; MGORS2	0.00189394	0.07105333757365873
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00189394	0.07105333757365873
APPARENT MINERALOCORTICOID EXCESS	0.00189394	0.07105333757365873
SECKEL SYNDROME 4	0.00189394	0.07105333757365873
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.07105333757365873
ISOTRETINOIN-LIKE SYNDROME	0.00189394	0.07105333757365873
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.07105333757365873
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00189394	0.07105333757365873
ELLIS VAN CREVELD SYNDROME	0.00189394	0.07105333757365873
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00189394	0.07105333757365873
VACTERL WITH HYDROCEPHALUS	0.00189394	0.07105333757365873
MECKEL SYNDROME 12; MKS12	0.00189394	0.07105333757365873
BLOOM SYNDROME	0.00189394	0.07105333757365873
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00189394	0.07105333757365873
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00189394	0.07105333757365873
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00189394	0.07105333757365873
LAMBERT SYNDROME	0.00189394	0.07105333757365873
BRANCHIO-OCULO-FACIAL SYNDROME	0.00189394	0.07105333757365873
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00189394	0.07105333757365873
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00189394	0.07105333757365873
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00189394	0.07105333757365873
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365873
NEUROFACIODIGITORENAL SYNDROME	0.00189394	0.07105333757365873
NEU-LAXOVA SYNDROME	0.00189394	0.07105333757365873
MITCHELL-RILEY SYNDROME; MTCHRS	0.00189394	0.07105333757365873
BLOOM SYNDROME	0.00189394	0.07105333757365873
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00189394	0.07105333757365873
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00189394	0.07105333757365873
BALLER-GEROLD SYNDROME	0.00189394	0.07105333757365873
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00189394	0.07105333757365873
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00189394	0.07105333757365873
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00189394	0.07105333757365873
HOLZGREVE SYNDROME	0.00189394	0.07105333757365873
19Q13.11 MICRODELETION SYNDROME	0.00189394	0.07105333757365873
HEMOCHROMATOSIS, NEONATAL	0.00189394	0.07105333757365873
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00189394	0.07105333757365873
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365873
ACRO-RENAL-MANDIBULAR SYNDROME	0.00189394	0.07105333757365873
FRAXE INTELLECTUAL DISABILITY	0.00189394	0.07105333757365873
AREDYLD SYNDROME	0.00189394	0.07105333757365873
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.07105333757365873
HARTSFIELD SYNDROME	0.00189394	0.07105333757365873
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00189394	0.07105333757365873
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00189394	0.07105333757365873
LEPRECHAUNISM	0.00189394	0.07105333757365873
TRIPLOIDY	0.00189394	0.07105333757365873
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00189394	0.07105333757365873
TRANSALDOLASE DEFICIENCY	0.00189394	0.07105333757365873
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00189394	0.07105333757365873
ATRESIA OF SMALL INTESTINE	0.00189394	0.07105333757365873
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.07105333757365873
MATTHEW-WOOD SYNDROME	0.00189394	0.07105333757365873
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00189394	0.07105333757365873
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00189394	0.07105333757365873
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.07105333757365873
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00189394	0.07105333757365873
GRACILE SYNDROME	0.00189394	0.07105333757365873
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00189394	0.07105333757365873
PEARSON SYNDROME	0.00189394	0.07105333757365873
CEREBROCOSTOMANDIBULAR SYNDROME	0.00189394	0.07105333757365873
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00189394	0.07105333757365873
3M SYNDROME	0.00189394	0.07105333757365873
PHAVER SYNDROME	0.00189394	0.07105333757365873
GENITOPALATOCARDIAC SYNDROME	0.00189394	0.07105333757365873
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00189394	0.07105333757365873
IMAGE SYNDROME	0.00189394	0.07105333757365873
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.07105333757365873
PHOCOMELIA, SCHINZEL TYPE	0.00189394	0.07105333757365873
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00189394	0.07105333757365873
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00189394	0.07105333757365873
TURNER SYNDROME	0.00189394	0.07105333757365873
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00189394	0.07105333757365873
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00189394	0.07105333757365873
JOHANSON-BLIZZARD SYNDROME; JBS	0.00189394	0.07105333757365873
TRICHOHEPATOENTERIC SYNDROME 2	0.00189394	0.07105333757365873
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00189394	0.07105333757365873
MEVALONIC ACIDURIA	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
SSR4-CDG	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
ELEJALDE DISEASE	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040779042368001395
SMITH-MAGENIS SYNDROME; SMS	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
STT3A-CDG	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
GRISCELLI SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.040779042368001395
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.040779042368001395
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040779042368001395
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME	0.001086973	0.040779042368001395
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.040779042368001395
SALLA DISEASE	0.001086973	0.040779042368001395
FUCOSIDOSIS	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
17Q12 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040779042368001395
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
15Q14 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
MONOSOMY 9P	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
8P11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001086973	0.040779042368001395
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 1Q	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
CK SYNDROME	0.001086973	0.040779042368001395
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
GRISCELLI SYNDROME TYPE 1	0.001086973	0.040779042368001395
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.001086973	0.040779042368001395
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
SIALIDOSIS TYPE 2	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040779042368001395
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
C SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
19P13.13 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MEND SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.040779042368001395
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
RING CHROMOSOME 22 SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
PIERPONT SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.040779042368001395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001086973	0.040779042368001395
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
LISSENCEPHALY 1; LIS1	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
RUBINSTEIN-TAYBI SYNDROME	0.001086973	0.040779042368001395
15Q13.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.040779042368001395
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040779042368001395
AICARDI-GOUTIÃˆRES SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001086973	0.040779042368001395
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.040779042368001395
MONOSOMY 9Q22.3	0.001086973	0.040779042368001395
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
WEAVER SYNDROME	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.040779042368001395
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040779042368001395
ANGELMAN SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
MEHMO SYNDROME; MEHMO	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
CHROMOSOME 10Q26 DELETION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.040779042368001395
SMITH-MAGENIS SYNDROME	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001086973	0.040779042368001395
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040779042368001395
48,XXXY SYNDROME	0.001086973	0.040779042368001395
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
EAST SYNDROME	0.001086973	0.040779042368001395
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
LISSENCEPHALY 8; LIS8	0.001086973	0.040779042368001395
HARTNUP DISEASE	0.001086973	0.040779042368001395
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.040779042368001395
COWDEN SYNDROME	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.040779042368001395
22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
PMM2-CDG	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001086973	0.040779042368001395
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.040779042368001395
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02046708582460892
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02046708582460892
ABETAL34V AMYLOIDOSIS	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02046708582460892
MARINESCO-SJÃ–GREN SYNDROME	0.000545554	0.02046708582460892
CURRY-JONES SYNDROME	0.000545554	0.02046708582460892
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02046708582460892
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02046708582460892
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 14	0.000545554	0.02046708582460892
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02046708582460892
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02046708582460892
JOUBERT SYNDROME 15	0.000545554	0.02046708582460892
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.02046708582460892
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02046708582460892
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02046708582460892
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02046708582460892
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02046708582460892
ALAZAMI SYNDROME; ALAZS	0.000545554	0.02046708582460892
CDAGS SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02046708582460892
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02046708582460892
ATELOSTEOGENESIS TYPE III	0.000545554	0.02046708582460892
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.02046708582460892
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02046708582460892
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.02046708582460892
48,XYYY SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.02046708582460892
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.02046708582460892
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
LIG4 SYNDROME	0.000545554	0.02046708582460892
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.02046708582460892
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
HURLER SYNDROME	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.02046708582460892
NOONAN SYNDROME 5; NS5	0.000545554	0.02046708582460892
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02046708582460892
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02046708582460892
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02046708582460892
JOUBERT SYNDROME 8	0.000545554	0.02046708582460892
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02046708582460892
HADZISELIMOVIC SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.02046708582460892
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.02046708582460892
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02046708582460892
RIDDLE SYNDROME	0.000545554	0.02046708582460892
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02046708582460892
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.02046708582460892
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02046708582460892
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02046708582460892
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02046708582460892
NOONAN SYNDROME 3; NS3	0.000545554	0.02046708582460892
FRIAS SYNDROME	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02046708582460892
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02046708582460892
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02046708582460892
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02046708582460892
LARSEN-LIKE SYNDROME	0.000545554	0.02046708582460892
3Q29 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.02046708582460892
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02046708582460892
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.02046708582460892
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.02046708582460892
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02046708582460892
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02046708582460892
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02046708582460892
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.02046708582460892
LIG4 SYNDROME	0.000545554	0.02046708582460892
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02046708582460892
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
TRANSKETOLASE DEFICIENCY	0.000545554	0.02046708582460892
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02046708582460892
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02046708582460892
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
FRIED SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02046708582460892
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.02046708582460892
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02046708582460892
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.02046708582460892
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02046708582460892
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02046708582460892
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02046708582460892
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02046708582460892
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02046708582460892
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02046708582460892
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
NOONAN SYNDROME 2; NS2	0.000545554	0.02046708582460892
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.02046708582460892
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02046708582460892
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02046708582460892
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02046708582460892
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02046708582460892
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02046708582460892
WEAVER SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 11	0.000545554	0.02046708582460892
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.02046708582460892
YUNIS-VARON SYNDROME	0.000545554	0.02046708582460892
AUSTRALIA ANTIGEN	0.000545554	0.02046708582460892
PROPIONIC ACIDEMIA	0.000545554	0.02046708582460892
RIGID SPINE SYNDROME	0.000545554	0.02046708582460892
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02046708582460892
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02046708582460892
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02046708582460892
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.02046708582460892
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02046708582460892
NOONAN SYNDROME 6; NS6	0.000545554	0.02046708582460892
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02046708582460892
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.02046708582460892
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02046708582460892
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02046708582460892
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02046708582460892
STEEL SYNDROME; STLS	0.000545554	0.02046708582460892
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
FRONTOOCULAR SYNDROME	0.000545554	0.02046708582460892
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02046708582460892
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02046708582460892
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02046708582460892
SEPTOOPTIC DYSPLASIA	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02046708582460892
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02046708582460892
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.02046708582460892
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02046708582460892
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02046708582460892
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02046708582460892
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02046708582460892
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02046708582460892
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02046708582460892
RAINE SYNDROME	0.000545554	0.02046708582460892
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02046708582460892
GERMAN SYNDROME	0.000545554	0.02046708582460892
OROTIC ACIDURIA	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02046708582460892
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02046708582460892
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.02046708582460892
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.02046708582460892
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02046708582460892
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02046708582460892
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02046708582460892
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02046708582460892
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02046708582460892
MECKEL SYNDROME 13; MKS13	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.02046708582460892
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02046708582460892
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.02046708582460892
3MC SYNDROME 2	0.000545554	0.02046708582460892
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.02046708582460892
TOLUENE EMBRYOPATHY	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.02046708582460892
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02046708582460892
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.02046708582460892
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02046708582460892
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02046708582460892
OCCIPITAL HORN SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02046708582460892
PELLAGRA-LIKE SYNDROME	0.000545554	0.02046708582460892
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02046708582460892
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02046708582460892
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02046708582460892
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02046708582460892
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02046708582460892
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02046708582460892
ICF SYNDROME	0.000545554	0.02046708582460892
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
3C SYNDROME	0.000545554	0.02046708582460892
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02046708582460892
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02046708582460892
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02046708582460892
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.02046708582460892
JAWAD SYNDROME	0.000545554	0.02046708582460892
TRISOMY 9P	0.000545554	0.02046708582460892
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02046708582460892
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02046708582460892
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02046708582460892
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02046708582460892
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02046708582460892
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
ZECHI-CEIDE SYNDROME	0.000545554	0.02046708582460892
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
NAVAJO NEUROHEPATOPATHY	0.000545554	0.02046708582460892
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02046708582460892
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.02046708582460892
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 28	0.000545554	0.02046708582460892
JOUBERT SYNDROME 27	0.000545554	0.02046708582460892
MEIER-GORLIN SYNDROME 7	0.000545554	0.02046708582460892
HYPERTRICHOSIS CUBITI	0.000545554	0.02046708582460892
NETHERTON SYNDROME; NETH	0.000545554	0.02046708582460892
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.02046708582460892
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.02046708582460892
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02046708582460892
HURLER SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02046708582460892
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.02046708582460892
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.02046708582460892
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.02046708582460892
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02046708582460892
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02046708582460892
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02046708582460892
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VI	0.000545554	0.02046708582460892
CODAS SYNDROME	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02046708582460892
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02046708582460892
OGDEN SYNDROME; OGDNS	0.000545554	0.02046708582460892
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02046708582460892
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
PENTASOMY X	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.02046708582460892
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02046708582460892
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02046708582460892
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02046708582460892
NOONAN SYNDROME 11; NS11	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02046708582460892
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02046708582460892
300270 ADRENOMYODYSTROPHY	0.000545554	0.02046708582460892
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.02046708582460892
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 10	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.02046708582460892
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02046708582460892
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02046708582460892
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02046708582460892
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02046708582460892
TRISOMY 12P	0.000545554	0.02046708582460892
ALG6-CDG	0.000545554	0.02046708582460892
DISTAL TRISOMY 18Q	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.02046708582460892
6Q16 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.02046708582460892
TRISOMY 8Q	0.000545554	0.02046708582460892
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.02046708582460892
TEMTAMY SYNDROME	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02046708582460892
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.02046708582460892
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
HOLMES-GANG SYNDROME	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02046708582460892
ROTHMUND-THOMSON SYNDROME	0.000545554	0.02046708582460892
WOLMAN DISEASE	0.000545554	0.02046708582460892
DEXTROCARDIA	0.000545554	0.02046708582460892
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02046708582460892
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02046708582460892
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02046708582460892
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.02046708582460892
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02046708582460892
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.02046708582460892
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02046708582460892
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02046708582460892
MONOSOMY 18P	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02046708582460892
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02046708582460892
DISTAL MONOSOMY 9P	0.000545554	0.02046708582460892
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02046708582460892
EVEN-PLUS SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02046708582460892
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02046708582460892
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02046708582460892
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02046708582460892
LATERAL MENINGOCELE SYNDROME	0.000545554	0.02046708582460892
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02046708582460892
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02046708582460892
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 2	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02046708582460892
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02046708582460892
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.02046708582460892
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02046708582460892
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02046708582460892
OGDEN SYNDROME	0.000545554	0.02046708582460892
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02046708582460892
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.02046708582460892
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02046708582460892
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.02046708582460892
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.02046708582460892
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02046708582460892
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02046708582460892
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02046708582460892
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02046708582460892
THYROID HEMIAGENESIS	0.000545554	0.02046708582460892
OPITZ G/BBB SYNDROME	0.000545554	0.02046708582460892
THYROID HYPOPLASIA	0.000545554	0.02046708582460892
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02046708582460892
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.02046708582460892
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02046708582460892
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02046708582460892
CULLER-JONES SYNDROME; CJS	0.000545554	0.02046708582460892
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02046708582460892
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02046708582460892
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02046708582460892
ALPHA-MANNOSIDOSIS	0.000545554	0.02046708582460892
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.02046708582460892
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02046708582460892
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02046708582460892
OXOGLUTARIC ACIDURIA	0.000545554	0.02046708582460892
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.02046708582460892
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02046708582460892
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02046708582460892
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.02046708582460892
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02046708582460892
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.02046708582460892
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02046708582460892
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.02046708582460892
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02046708582460892
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.02046708582460892
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.02046708582460892
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.02046708582460892
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02046708582460892
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02046708582460892
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02046708582460892
MONOSOMY 13Q34	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02046708582460892
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02046708582460892
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.02046708582460892
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02046708582460892
AL-RAQAD SYNDROME; ARS	0.000545554	0.02046708582460892
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02046708582460892
THYROID ECTOPIA	0.000545554	0.02046708582460892
TETRASOMY X	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02046708582460892
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.02046708582460892
AU-KLINE SYNDROME; AUKS	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02046708582460892
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02046708582460892
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.02046708582460892
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02046708582460892
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.02046708582460892
NOONAN SYNDROME 9; NS9	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02046708582460892
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02046708582460892
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02046708582460892
MIETENS SYNDROME	0.000545554	0.02046708582460892
LAMB-SHAFFER SYNDROME	0.000545554	0.02046708582460892
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02046708582460892
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02046708582460892
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02046708582460892
JOUBERT SYNDROME 26	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02046708582460892
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02046708582460892
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02046708582460892
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.02046708582460892
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02046708582460892
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02046708582460892
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02046708582460892
ATHYREOSIS	0.000545554	0.02046708582460892
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02046708582460892
CHOPS SYNDROME; CHOPS	0.000545554	0.02046708582460892
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02046708582460892
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.02046708582460892
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.02046708582460892
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.02046708582460892
JOUBERT SYNDROME 25	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02046708582460892
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
ANGELMAN SYNDROME	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392472
COG8-CDG	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
SJÃ–GREN-LARSSON SYNDROME	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
RETT SYNDROME	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392472
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392472
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
CAMOS SYNDROME	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
PROTEUS SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392472
ADDISON DISEASE	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
MEHMO SYNDROME	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
LASSA FEVER	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392472
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392472
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020311956543392472
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.020311956543392472
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
LATHOSTEROLOSIS	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392472
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392472
CYCLIC VOMITING SYNDROME	0.000541419	0.020311956543392472
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392472
FABRY DISEASE	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392472
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392472
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392472
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392472
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392472
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020311956543392472
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392472
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020311956543392472
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020311956543392472
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392472
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392472
CROME SYNDROME	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392472
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.020311956543392472
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392472
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
PHENYLKETONURIA	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
GITELMAN SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392472
GAPO SYNDROME; GAPOS	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392472
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
OHDO SYNDROME	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
LEIGH SYNDROME	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
MOYNAHAN SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
14Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392472
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392472
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
DDOST-CDG	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392472
HENNEKAM SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
MOWAT-WILSON SYNDROME	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392472
KABUKI SYNDROME	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
TEMPLE-BARAITSER SYNDROME	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392472
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392472
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
CHIME SYNDROME	0.000541419	0.020311956543392472
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
DUPLICATION/INVERSION 15Q11	0.000541419	0.020311956543392472
TETRASOMY 18P	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392472
WHIPPLE DISEASE	0.000541419	0.020311956543392472
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392472
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392472
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392472
ATAXIA-TELANGIECTASIA	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020311956543392472
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392472
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020311956543392472
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392472
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
COCKAYNE SYNDROME	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
C SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392472
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392472
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392472
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392472
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392472
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
CRISPONI SYNDROME	0.000541419	0.020311956543392472
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
